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Title: Autophagy as a cell fate determinant facing drugs and trophic-nutritional deprivation 
 
1 Abstract 
Cell death is an indispensable event during mammalian lifespan. A morphological classification defined 
apoptosis, necrosis and autophagy as the three main types of cell death. Apoptosis (type I) is characterized 
by a mechanism of cell suicide adopted by multicellular organisms to shape organs and tissues. In addition, 
apoptosis is commonly engaged in response to traditional radio- and chemotherapy treatments of cancer. 
Autophagy is the main lysosomal degradative program for the turnover of organelles, long-living proteins 
and the generation of metabolites during cell conditions of starvation. Autophagy represents also a means 
of cell suicide (type II or autophagic cell death). Moreover, autophagy can be placed upstream of other 
modalities of cell death. Finally, necrosis (type III) is characterized by the disruption of the plasma 
membrane in response to accidental cues or, alternatively, to the activation of genetically-regulated 
pathways. 
 
In the first part of our study, we analyzed the contribution of autophagy to the cell death in several cell lines 
exposed to a complete trophic and nutritional deprivation by means of a specific starvation medium (SM). 
The cell cultures deprived of growth factors, glucose and other nutrients mimic the most severe scenario in 
an insufficiently vascularized tumor. Deprived cells responded by triggering autophagy and apoptosis by 
the intrinsic pathway. In this experimental paradigm, autophagy accomplished a dual role. At short times, 
it primes the mitochondrial outer membrane permeabilization (MOMP). In cells subjected to SM, the 
inhibition of canonical autophagy by means of genetics (ATG 5 -/- and Beclin-1 siRNA) or pharmacology 
with 3-methyladenine (3-MA) limited MOMP, the release of cytochrome C and the subsequent activation 
of caspases. However, at long times, the pro-survival function of autophagy prevailed, thus underscoring 
the temporal frame of the phenomena. In addition, starved cells subjected to pro-apoptotic drugs such as 
staurosporine, camptothecin or etoposide were protected from apoptosis if autophagy was either genetically 
or pharmacologically disabled. These observations are relevant for the better understanding of the response 
to anticancer drugs of solid tumors with a deficient irrigation. 
 
Phenylethinesulfonamide (PES), also known as Pifithrin-µ, is known for its ability to disrupt some 
homeostatic networks such as the proper refolding of proteins by HSP70, autophagy, the ubiquitin 
proteasome system (UPS) and the translocation of p53 to mitochondria. PES has raised a great interest 
because of its lethal selectivity for cancer cells. In our cell models, PES induced a non-necroptotic 
regulated-type of necrosis that depended on the partnership of p53 and reactive oxygen species (ROS). 
Accordingly, p53-deficiency or thiol antioxidants protected cells in culture from PES-induced cell death. 
Consistently, the depletion of glutathione by means of L-buthionine-sulfoximine (BSO) sensitized cells to 
PES. Therefore, BSO association with PES defined a promising synergism envisaging cancer therapy. 
Unexpectedly, Bax -/- and Bax -/-/Bak -/- (DKO) MEFs displayed greater sensitivity to PES-elicited necrosis 
than their wild-type (WT) counterparts. Reintroduction of a functional BAX protein protected BAX 
deficient cells from PES cytotoxicity. This fact was indicating a pro-survival function in BAX that is rarely 
observed. The presence of increased mitochondrial fusion in WT MEFs, those with increased resilience, 
suggested a potential role for mitochondrial dynamics in the mode of action of PES. This was proved by 
means of Mdivi-1, a chemical inducer of mitochondrial fusion. Cells with fused mitochondria were better 
tolerating the treatments with PES. Moreover, BAX deletion minimized the protective effect of Mdivi-1, 
thus suggesting the involvement of BAX in promoting mitochondrial fusion. 
 
In conclusion, in the context of trophic and nutritional deprivation (SM), we have identified time as the 
determinant factor in the autophagy-mediated transition from a pro-death apoptotic program to a pro-
survival one. In addition, we have investigated the lethal mode of action of PES and uncovered a feed-back 
network comprising p53, ROS, BAX and mitochondrial dynamics.   
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Títol: L’autofàgia com a determinant del destí cel· lular front a fàrmacs i privació tròfica-nutricional 
2 Resum 
La mort cel·lular és un esdeveniment indispensable al llarg de la vida dels mamífers. Una classificació 
morfològica definia apoptosi, necrosi i autofàgia com els tres principals tipus de mort cel· lular. L’apoptosi 
(tipus I) es caracteritza per un mecanisme de suïcidi cel· lular que ha estat adoptat pels organismes 
multicel·lulars per a estructurar el òrgans i els teixits. A més, l'apoptosi és generalment activada en resposta 
als tractaments convencionals de ràdio- i quimioteràpia del càncer. L’autofàgia és el principal programa de 
degradació lisosomal per al reciclatge dels orgànuls, les proteïnes de llarga vida i la generació de metabòlits 
en condicions de privació nutricional de les cèl·lules. La autofàgia representa també un mecanisme suïcida 
cel· lular (el tipus II o de mort cel·lular per autofàgia). És més, l’autofàgia es pot situar apicalment regulant 
altres modalitats de mort cel·lular. Finalment, la necrosi (el tipus III) es caracteritza per la disrupció de la 
membrana plasmàtica en resposta a situacions accidentals o, alternativament, a l'activació de vies regulades 
genèticament. 
 
A la primera part del nostre estudi, hem analitzat la contribució de l'autofàgia a la mort cel·lular en diverses 
línies de cèl·lules exposades a una privació completa tròfica i nutricional mitjançant un medi de cultiu 
específic (SM). Els cultius cel·lulars privats de factors de creixement, la glucosa i altres nutrients imiten 
l'escenari de major severitat dintre d'un tumor insuficientment vascularitzat. Les cèl·lules privades responien 
mitjançant l'activació de l'autofàgia i l'apoptosi per la via intrínseca. En aquest paradigma experimental, 
l'autofàgia complia una doble funció. A temps curts, promovia la permeabilització de la membrana externa 
mitocondrial (MOMP). En cèl· lules sotmeses a SM, la inhibició de l'autofàgia canònica per mitjans genètics 
(Atg 5 -/- i Beclina-1 siRNA) o farmacològics amb 3-metiladenina (3-MA) limitava la MOMP, l'alliberament 
de citocrom C i la subseqüent activació de les caspases. En canvi, a temps llargs, la funció pro-supervivència 
de l'autofàgia prevalia, emfatitzant-se així el marc temporal dels fenòmens. Addicionalment, les cèl·lules 
sota privació sotmeses a fàrmacs pro-apoptòtics com ara estaurosporina, camptotecina o etopòsid eren 
protegides de l’apoptosi si l’autofàgia estava interferida genèticament o farmacològica. Aquestes 
observacions són rellevants per entendre millor la resposta als medicaments anticancerosos dels tumors sòlids 
amb irrigació insuficient. 
 
La feniletísulfonamida (PES), també coneguda com Pifithrina-µ, és coneguda per la seva capacitat d'alterar 
algunes xarxes homeostàtiques com ara el correcte replegament de proteïnes per HSP70, l'autofàgia, el 
sistema ubiqüitina-proteosoma (UPS) i la translocació de p53 a les mitocòndries. PES desperta un gran interès 
per la seva letalitat selectiva cap a les cèl· lules canceroses. En els nostres models cel· lulars, PES va induir 
un tipus de necrosi, regulat i no necroptotic que depenia de l'associació de p53 i espècies reactives d'oxigen 
(ROS). En conseqüència, la deficiència en p53 o els antioxidants tiòlics protegien les cèl· lules en cultiu de 
la mort cel·lular induïda per PES. En coherència, l'esgotament de glutatió per mitjà de L-butionina-
sulfoximina (BSO) sensibilitzava les cèl· lules front a PES. En conseqüència, l’associació de BSO amb PES 
definia un sinergisme prometedor de cara a la teràpia del càncer. Inesperadament, Bax -/- i Bax -/- més Bak -/- 
(DKO) MEFs mostraven una major sensibilitat a la necrosi provocada per PES que la seva variant salvatge 
(WT). La reintroducció d'una proteïna BAX funcional a les cèl·lules deficients en BAX protegia de la 
citotoxicitat de PES. Aquest fet indicava una funció de pro-supervivència en BAX que rarament s’observa. 
La presència d’un increment en la fusió de les mitocòndries als WT MEFs, que mostren una major resistència, 
va suggerir un potencial paper de la dinàmica mitocondrial en el mecanisme d'acció de PES. Això es va 
demostrar per mitjà de Mdivi-1, un inductor químic de fusió mitocondrial. Les cèl· lules amb mitocòndries 
fusionades toleraven millor els tractaments amb PES. És més, el dèficit de BAX minimitzava l'efecte 
protector de Mdivi-1, fet que suggeria la participació de BAX en promoure la fusió mitocondrial. 
 
En conclusió, en el context de la privació tròfic i nutricional (SM), hem identificat el temps com el factor 
determinant pel qual l’autofàgia genera la transició d'un programa pro-apoptòtic de mort a un de pro-
supervivència. Addicionalment, hem investigat el mecanisme d’acció letal de PES i descobert una xarxa de 
retroalimentacions que inclou a p53, ROS, BAX i la dinàmica mitocondrial. 
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Título: La autofagia como determinante del destino celular frente a fármacos y privación trófico-
nutricional 
 
3 Resumen 
La muerte celular es un evento indispensable a lo largo de la vida de los mamíferos. Una clasificación 
morfológica definía apoptosis, necrosis y autofagia como los tres principales tipos de muerte celular. La 
apoptosis (tipo I) se caracteriza por un mecanismo de suicidio celular que ha sido adoptado por los organismos 
multicelulares para estructurar los órganos y los tejidos. Además, la apoptosis es generalmente activada en 
respuesta a los tratamientos convencionales de radio- y quimioterapia del cáncer. La autofagia es el principal 
programa de degradación lisosomal para el reciclaje de los orgánulos, las proteínas de larga vida y la 
generación de metabolitos en condiciones de privación nutricional de las células. La autofagia representa 
también un mecanismo suicida celular (el tipo II o de muerte celular por autofagia). Es más, la autofagia puede 
situarse apicalmente regulando otras modalidades de muerte celular. Finalmente, la necrosis (el tipo III) se 
caracteriza por la disrupción de la membrana plasmática en respuesta a situaciones accidentales o, 
alternativamente, a la activación de vías reguladas genéticamente. 
 
En la primera parte de nuestro estudio, hemos analizado la contribución de la autofagia en la muerte celular de 
varias líneas de células expuestas a una privación completa trófica y nutricional mediante un medio de cultivo 
específico (SM). Los cultivos celulares privados de factores de crecimiento, la glucosa y otros nutrientes imitan 
el escenario de mayor severidad dentro de un tumor insuficientemente vascularizado. Las células privadas 
respondían mediante la activación de la autofagia y la apoptosis por la vía intrínseca. En este paradigma 
experimental, la autofagia cumplía una doble función. A tiempo cortos, promovía la permeabilización de la 
membrana externa mitocondrial (MOMP). En células sometidas a SM, la inhibición de la autofagia canónica 
por medios genéticos (Atg 5 - / - y Beclina-1 siRNA) o farmacológicos con 3-metiladenina (3-MA) limitaba la 
MOMP, la liberación de citocromo C y la subsecuente activación de las caspasas. En cambio, en tiempos 
largos, la función pro-supervivencia de la autofagia prevalecía, enfatizando así el marco temporal de los 
fenómenos. Adicionalmente, las células bajo privación sometidas a fármacos pro-apoptóticos como 
estaurosporina, camptotecina o etopósido eran protegidas de la apoptosis si la autofagia estaba interferida 
genética o farmacológicamente. Estas observaciones son relevantes para entender mejor la respuesta a los 
medicamentos anticancerosos de los tumores sólidos con irrigación insuficiente. 
 
La feniletinosulfonamida (PES), también conocida como Pifithrina-µ, es conocida por su capacidad de alterar 
algunas redes homeostáticas como el correcto repliegue de proteínas por HSP70, la autofagia, el sistema 
ubiquitina-proteosoma (UPS) y la translocación de p53 a las mitocondrias. PES despierta un gran interés por 
su letalidad selectiva hacia las células cancerosas. En nuestros modelos celulares, PES indujo un tipo de 
necrosis, regulado y no necroptótico que dependía de la asociación de p53 y las especies reactivas de oxígeno 
(ROS). En consecuencia, la deficiencia de p53 o los antioxidantes tiólicos protegían las células en cultivo de 
la muerte celular inducida por PES. En coherencia, el agotamiento de glutatión por medio de L-butionina-
sulfoximina (BSO) sensibilizaba las células frente a PES. En consecuencia, la asociación de BSO con PES 
definía un sinergismo prometedor de cara a la terapia del cáncer. Inesperadamente, Bax -/- y Bax -/- más Bak -/- 
(DKO) MEFs mostraban una mayor sensibilidad a la necrosis provocada por PES que su variante salvaje (WT). 
La reintroducción de una proteína BAX funcional a las células deficientes en BAX protegía de la citotoxicidad 
de PES. Este hecho indicaba una función pro-supervivencia en BAX que raramente se observa. La presencia 
de un incremento en la fusión de las mitocondrias en los WT MEFs, que muestran una mayor resistencia, 
sugirió un potencial papel de la dinámica mitocondrial en el mecanismo de acción de PES. Esto se demostró 
mediante Mdivi-1, un inductor químico de fusión mitocondrial. Las células con mitocondrias fusionadas 
toleraban mejor los tratamientos con PES. Es más, el déficit de BAX minimizaba el efecto protector de Mdivi-
1, lo que sugería la participación de BAX en promover la fusión mitocondrial. 
 
En conclusión, en el contexto de la privación trófico y nutricional (SM), hemos identificado el tiempo como 
el factor determinante por el que la autofagia genera la transición de un programa pro-apoptótico de muerte a 
uno de pro-supervivencia. Adicionalmente, hemos investigado el mecanismo de acción letal de PES y 
descubierto una red de retroalimentaciones que incluye a p53, ROS, BAX y la dinámica mitocondrial 
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III PREFACE 
 
Cell Death on the verge of Biology and Philosophy 
 
“Se la morte, signor mio, fosse come uno di quegli insetti 
strani, schifosi, che qualcuno inopinatamente ci scopre 
addosso... Lei passa per via; un altro passante, all'improvviso, 
lo ferma e, cauto, con due dita protese le dice: «Scusi, 
permette? lei, egregio signore, c’ ha la morte addosso ». E con 
quelle due dita protese, la piglia e la butta via... Sarebbe 
magnifica! Ma la morte non è come uno di questi insetti 
schifosi. Tanti che passeggiano disinvolti e alieni, forse ce 
l'hanno addosso; nessuno la vede; ed essi pensano quieti e 
tranquilli a ciò che faranno domani e doman l'altro.” 
 L’uomo dal fiore in bocca. Luigi Pirandello. 
 
"Death is the turn of the road, dying is only not be 
seen."  Fernando Pessoa.       
Death stands there in the background, but don’t be afraid. Hold 
the watch down with one hand, take the stem in two fingers, 
and rotate it smoothly. Now another installment of time opens, 
trees spread their leaves, boats run races, like a fan time 
continues filling with itself, and from that burgeon the air, the 
breezes of earth, the shadow of a woman, the sweet smell of 
bread. 
What did you expect, what more do you want? Quickly strap 
it to your wrist, let it tick away in freedom, imitate it greedily. 
Fear will rust all the rubies, everything that could happen to it 
and was forgotten is about to corrode the watch’s veins, 
cankering the cold blood and its tiny rubies. And death is there 
in the background, we must run to arrive beforehand and 
understand it’s already unimportant. 
Cronopios and Famas. Julio Cortázar. 
 
“With the exception of mankind, all creatures are immortal, for 
they know nothing of death.” 
The Immortal, Aleph. Jorge Luis Borges. 
 
“Have you ever wondered if death is the same for all living 
beings, be they animals, human beings included, or plants, 
from the grass you walk on to the hundred-meter-tall 
sequoiadendron giganteum, will the death that kills a man who 
knows he's going to die be the same as that of a horse who 
never will.”                                                                        
Death at Intervals. José Saramago, 
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Under optimal growing conditions, most prokaryotes and unicellular eukaryotes are potentially immortal. 
Their immortality is justified by their mechanisms of asexual reproduction, which allows the generation of 
two identical offspring from a single parent cell, in a process termed binary fission. However, some studies 
have underscored the intriguing possibility that regulated cell death of unicellular organisms (e.g. bacteria, 
yeast) responds to an altruistic attempt to benefit the entire colony 1. 
 
In multicellular organisms, the concept of altruistic cell death is utterly relevant. Cell death in this context is 
an indispensable event. In order to first, develop and later, maintain a healthy state, individual cells divide, 
specialize or commit suicide. In this scenario, death of cells offers undoubted beneficial effects for the 
survival of the organism they belong to.  
The passage from uni- to multi-cellularity has driven an evolutionary pressure for the appearance of both 
genetically regulated cell death programs. The discovery of regulated cell death (RCD) dates to the 
pioneering studies of the nematode Caenorhabditis elegans. The investigation of genetic mutants from this 
worm revealed that cell death by apoptosis was contingent on the presence of a death machinery, which 
comprise 4 genes: an activator (ced-4), an executioner (ced-3), a repressor of cell death (ced-9) and the 
antagonist of ced-9 (egl-1). In higher eukaryotes, the cell death network has reached its acme of complexity 
and the three main mechanisms of cell death (apoptosis, necrosis and autophagic cell death) are controlled 
by more than 100 key genes.  
 
Higher multicellular organisms are not immortal and their reproduction depends essentially on sexual 
mechanisms. Within the same species, the idea of the death of a single individual as an altruistic adaptation 
(for the greater benefit of the species as a whole), can be traced back to August Weismann and Charles 
Darwin, two of the most notable evolutionary theorists of the 19th century. Nevertheless when dealing with 
human beings, such a concept requires a more complex multidisciplinary pondering. Human being is in fact 
the only creature who strives within a paradox: an ethereal “symbolic identity” caged in an evanescent body. 
As the American anthropologist Ernest Becker wrote:  
 
“Man is literally split in two: He has an awareness of his own splendid uniqueness in that he sticks 
out of nature with a towering majesty, and yet he goes back into the ground a few feet in order blindly 
and dumbly to rot and disappear forever.” … “He is out of nature and hopelessly in it” 1. 
 
Such terrible conflict represents our existential background. All the other animals are spared this 
contradiction, for they live an unconsciousness and therefore timeless life. Existentialism is an attitude that 
dates back to ancient Greek philosophers, Heraclitus, Plato and Socrates and medieval thinkers such as Saint 
Augustin. Schopenhauer considered death as “the muse of philosophy” and the awareness of death - he 
continued - has been one of the strongest impulses to its birth 2.  
 
Ancient Greek scholars, especially Plato and Socrates, primarily focused on the dichotomy ”body versus 
mind” - that is, the relationship between physical reality and phenomenology - a theme that interested many 
following philosophers (Descartes, Kant and Husserl among others) and still challenges modern 
neurophysiology and artificial intelligence.  
 
 
For many ancient and modern religions the death-rebirth cycle or the promise of an eternal life after death 
was and still represents the only possible existential answer.   
                                                          
1
 Becker, Ernest (1973). The Denial of Death. New York: Simon & Schuster. 
 
2
 Schopenhauer, Arthur (1909). The World as Will and Idea. 
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Philosophy has instead employed many logical stratagems to deny death or alternatively to soften its burden, 
but “death turns its deaf ear to the invites of philosophy” 3. Some philosophical currents, like Stoicism and 
Epicureanism involved the devaluation of death but in an antithetical manner: the former hanging on life lack 
of meaning, the latter exalting it. Other philosophers, including for example Hegel, Spinoza, Feuerbach and 
Marx, had instead looked at the death of an individual within a sort of evolutionistic perspective.  
 
Heidegger and Kierkegaard are considered the fathers of modern Existentialism. Their ideas, which focused 
on the concept of anguish, have influenced psychology, arts and literature. The term Existentialism was 
precisely coined by the French philosopher Jean-Paul Sartre and it was retroactively applied to philosophers 
of the 19th and 20th century, whose thinking was characterized by putting the existence (“Being”) on top of 
the essence (“Nature”), reflecting on how “The existence precedes the essence”. 4  Existentialism can be 
defined as the attempt to understand the interlinks between existence and consciousness. 
 
The problem of existence and the ultimate and deep meaning of death has had such a strong impact in 
philosophy that Camus, in his famous absurdist essay “The Myth of Sisyphus” declares:  
 
“There is but one truly serious philosophical problem, and that is suicide. Judging whether life is or 
is not worth living amounts to answering the fundamental question of philosophy. All the rest— 
whether or not the world has three dimensions, whether the mind has nine or twelve categories—
comes afterwards. These are games; one must first answer”. 5 
 
Paraphrasing Camus’ statement and passing from the general (“Being”) to its particular (“Cell”), the same 
judgment can be stated regarding cellular death. In the context of a multicellular organism, the presence of 
an intrinsic death machinery to “judge” whether a cell is worth living or not, means the actual survival of the 
individual. Overall, the comprehension of the mechanisms by which a cell encounters its death is a 
fundamental challenge for medicine and a key for cancer, neurodegeneration, cerebral stroke, heart failure 
and autoimmune diseases therapy. 
 
 
                                                          
3
 Morin, Edgar (1976). L'Homme et la Mort. 
 
4
 Sartre, Jean-Paul (1943). Being and Nothingness. Gallimard. 
 
5
 Camus, Albert (1942). The Myth of Sisyphus. Gallimard.    
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IV INTRODUCTION 
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1 Classification of Cell Death 
According to the recommendations of the Nomenclature Committee on Cell Death (NCCD) 2015, two are 
the main criteria to identify a dead cell: irreversible plasma membrane permeabilization and/or complete 
fragmentation of the cell, including its nucleus 2.  
 
Cell death can be classified on the basis of its morphological, functional, immunological or biochemical 
features 3. In the following sections, we will develop the aforementioned classifications. 
 
1.1 Morphological classification of cell death  
One of the first attempts to classify cell death dates back to the 70’s when Schweichel and Merker described 
the morphological traits of cell demise during the fetal development of rats and mice 4. The lysosomal 
involvement was determinant to propose the following three cell death modalities: type I or heterophagy 
(Apoptosis), type II or Autophagic cell death and type III or non-lysosomal cell death (Necrosis). In the 90’s, 
this classification was revisited by Clarke, albeit maintaining the previous three developmental cell death 
paradigms 5. 
 
Each cell death modality is characterized by a specific ultrastructural appearance (Fig. 1):  
• Apoptosis is characterized by cytoplasmic shrinkage, chromatin condensation that classically 
initiates at the nuclear membrane (marginalization) and that is then extended to the whole nucleus 
(pyknonis), nuclear fragmentation (karyorrhexis), minimal perturbation of the organelles and the 
presence of a peculiar boiling-like (“blebbing”) process, which ends up with the cellular 
fragmentation into sealed membrane vesicles, termed apoptotic bodies.  
• Autophagic cell death is characterized by large-scale autophagic vacuolization of the cytoplasm. 
• The main morphological change of necrotic cell death is the cellular swelling (oncosis), rounding of 
the cell, organelle swelling, translucent and structurally disorganized cytoplasm, a largely intact 
distended nucleus and, eventually, the plasma membrane rupture. 
 
 
 
 
Figure 1: Morphological features of cell death by transmission electron microscopy. a) Type I or Apoptotic  cell death 
morphology with nuclear shrinkage and pyknosis. b) Type II or autophagic cell death with extensive presence of double 
membrane cytoplasmic autophagolysosome (arrows), filled with cytoplasmic content and organelles. c) Type III or 
Necrosis with intact nucleus (N), massive dismantled cytoplasm and plasma membrane rupture. Adapted from Cell Death 
and Differentiation (2007) 14, 1237–1243. 
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1.2 Functional Classification of Cell death 
On a functional basis, cell death can proceed through accidental or regulated manner. Accidental Cell death 
is triggered in response to a severe physical (e.g. high temperature), chemical (e.g. detergents or extreme 
change of pH) or mechanical (shearing) insult. It is characterized by its immediacy and insensitivity to any 
pharmacologic or genetic approach. On the other hand, regulated cell death involves a genetically-encoded 
molecular machinery. This machinery can be externally regulated by the inhibition of the lethal transduction 
signal or by improving the capacity to mount an adaptive response. The term Programmed cell death (PCD) 
refers to a subroutine of regulated cell death that occurs during development or, in the adult, to preserve the 
physiological tissue homeostasis and tune the immune response.  
 
1.3 Immunological classification of Cell death 
Cell death can be also divided in immunogenic or tolerogenic, depending on whether it induces or not an 
immune system response. The immunological response relies on the release of several danger signals called 
damage-associated molecular patterns (DAMPs). The emission of DAMPs was initially considered a feature 
of necrotic cell death. However, it is presently known that DAMPs are also released by apoptotic cells 
subjected to certain chemotherapeutic agents (e.g. Anthracycline and oxaliplatin), hypericin photodynamic 
therapy (PDT) or bortezomib treatment 6. 
The mechanism of DAMPs emission is context and agent-dependent. DAMPs can be either released to the 
extracellular environment, as in the case of ATP and high mobility group protein B1 (HMGB1) or exposed 
on the external outer membrane, like in the case of calcireticulin (CRT) and heat shock protein 90 (HSP90). 
Interestingly, the ATP release by injured or stressed cells strictly relies on autophagy 7. Once released, 
extracellular ATP will bind to the purinergic receptors (P2Y2 and P2X7) of macrophages and dendrocytes 
and function as a “find-me” signal. CRT exposure is triggered by a pre-mortem endoplasmic reticulum (ER) 
stress and the induction of radical species of oxygen (ROS). As for ATP releasing cells, CRT-exposing cells 
are recognized by CD91 positive cells (macrophages and dendrocytes) and engulfed. HMGB1, the most 
abundant non-histonic nuclear protein can be released either during accidental or regulated forms of cell 
death. Released HMGB1 interacts with Toll like receptor 4 (TLR4) of both immune and non-immune cells 
and triggers a local pro-inflammatory response. 
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1.4 Biochemical classification of cell death  
The biochemical classification of cell death relies on the main molecular events associated to each cell death 
modality.  In Table 1, the biochemical and structural traits of the three main modalities of cell death are 
summarized.  
 
 Table 1: Biochemical, features of apoptosis, necrosis and autophagy. Adapted from Br J Pharmacol. (2014) Apr; 171(8):2000-16 
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2 Apoptosis 
Apoptosis derives from the Greek word ἀπόπτωσις meaning “falling off”, as leaves from a tree in autumn. 
This term was coined by Kerr and collaborators to designate a type of cell death characterized by specific 
morphological traits 8. Apoptosis is a very selective and sophisticated process involved in both physiological 
and pathological conditions. During embryonic and fetal development, apoptosis functions as the main 
mechanism of programmed cell death (PCD) for tissue sculpting and molding, canalization of ducts and 
tubes, formation of digits and deletion of unneeded structures 9. After birth, apoptosis is involved in 
mammalian homeostatic processes. For instance, it orchestrates the clearance of approximately 60 billion of 
unwanted or dangerous cells per day. In the adult organism, apoptosis is also in charge of highly relevant 
processes such as the normal tissue turnover (skin, intestinal crypts) and the organ involution after withdrawal 
of trophic hormones (prostate, endometrium and mammary tissue) 10. 
Evasion of apoptosis is a hallmark of cancer and an important complement to the pro-oncogene activation 
during cancer development 11, 12. Genetic alterations in both intrinsic and extrinsic apoptotic pathways are 
common defects during tumorigenesis. For example, the B-Cell CLL/Lymphoma 2 (BCL-2) gene was 
discovered when studying a translocation between chromosome 14 and 18, a common genetic occurrence in 
follicular non-Hodgkin lymphoma. In general, the genetic or epigenetic deregulation of several anti-apoptotic 
BCL-2 family members represents a characteristic feature of numerous forms of cancers, which finally will 
translate into an increased resistance to chemo and radiotherapy. In the case of extrinsic pathway, the 
combination of epigenetic changes, down-regulation of death receptors (DR) and the overexpression of DR-
related decoy receptors are commonly observed events. Nonetheless, the most usual alterations of the 
apoptotic machinery affect some of its upstream regulators, such as p53, class I phosphoinositol-3-kinase 
(PI3K)/AKT or the NF-κB pathway.  
Caspase-dependent apoptosis is a type of regulated cell death (RCD) controlled by a complex cascade of 
events and activated by various triggers. The most distinctive trait is the activation of a family of proteases 
termed caspases, which are the executioners of the cell demise process.  
Caspases are a family of cysteine proteases that can hydrolyze peptide bonds on the carboxyl side of aspartate 
residues. This fact explains the nomenclature adopted, C (cys)- Asp (Aspartate)- ases. The active site consists 
of a pentapeptide sequence, which contains a nucleophilic cysteine residue within a conserved motif QACXG 
(C, Cysteine, X can be R, Q or G) 13. 
Caspases are first synthesized under the form of inactive zymogens termed pro-caspases. A pro-caspase 
consists of a N-terminal pro-domain (between 3 and 24 kDa), a large subunit (termed p20), which contains 
the caspase active site, and a C-terminal small subunit (termed p10). 
Caspases can be classified on the basis of multiple parameters, for instance, the context of their activation. 
Based on this parameter, there are caspases that get active during apoptosis (caspase-2 -3, -6, -7, -8, -9, -10) 
while others are engaged during inflammation (caspase-1,-4,-5,-12L). The former classification difficults 
inclusion of caspase-12S and -14 in any of the previous groups. Alternatively, caspases can be classified on 
the basis of the position they occupy in the activation cascade. Initiator (or apical) caspases are characterized 
by the presence of an interaction domain (pro-domain) that allows the assembly into macromolecular 
activating complexes. On the other hand, executioner (or effector) caspases are placed downstream of the 
apical ones. As depicted in Fig 2, initiator caspases involved in intrinsic pathway (e.g. caspase-9) contain a 
caspase recruitment domain (CARD), while initiator caspases involved in the extrinsic one (e.g. caspase-8) 
hold a death effector domain (DED) that allows the interaction with different type of adapters (see below). 
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Figure 2. Domain structure and functional classification of mammalian caspases. Based on their activation, caspases can 
be classified into inflammatory and apoptotic. Caspases involved in apoptosis are further subdivided into initiator and 
executioner. Caspase 12-S and -14 are depicted in an unclassified group. CARD, caspase recruitment domain; DED, death 
effector domain. From Cold Spring Harb Perspect Biol. 2013 Apr 1;5(4). 
 
Initiator pro-caspases normally exist as monomers in the cytosol. When the apoptotic stimulus is elicited, 
they associate and become active after dimerization within a large complex of proteins and adapters. 
Executioner caspases routinely exist as inactive dimers and become active in response to the cleavage by 
initiator caspases. This cut, which occurs between the large and the small domain, allows a conformational 
change and activation of the proteolytic site. The cleavage site contains aspartate residues, suggesting the 
possibility of an activation loop to amplify the initial cascade.  
Once activated, executioner caspases-3 and -7 selectively target several hundred of substrates, while caspase-
6, activated by caspase-3, cleaves a smaller group of poly-peptides. Cleavage of specific substrates by 
caspases contributes to the morphological and biochemical changes during apoptosis. For example, caspases 
target structural proteins such as filaments of actin, intermediate filaments, lamin A, lamin B, cytokeratins, 
On the other hand, Caspases cleave ICAD (inhibitor of caspase-activated deoxyribonuclease), a chaperone 
and inhibitor of the caspase-activated deoxyribonuclease (CAD). This event is central to initiate the cleavage 
of internucleosomal DNA, which is one of the most characteristic events to disable the functionality of a cell. 
In addition caspases cleave many protein kinases. This event can result in the inactivation of certain kinases 
or, alternatively, in the activation of others. The caspase-mediated fragmentation of protein kinase C, for 
instance, catalyzes the transfer of phosphatidylserine from the inner to the outer plasmatic membrane. Of 
note, this phenomenon is not a requirement for apoptosis to proceed and it seems to be                                        
stimulus-dependent 2.  In Table 2, a list of the main substrates of executioner caspases is summarized. 
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Table 2: List of the main substrates of executioner caspases. The table classifies the proteolytic substrates of caspases 
according to their cellular function. 
 
 
Caspase-dependent apoptotic cell death can occur through two well-differentiated pathways: the extrinsic 
and the intrinsic pathway (Fig 3). Both routes comprise 3 distinct phases: initiation, integration/decision and 
execution/degradation. The initiation stage is stimuli- and cell type-dependent. The phase of 
integration/decision is in charge of integrating information about internal, external pro- and anti-apoptotic 
cues. During this phase the “decision to die” is taken and the point of no return or commitment, is trespassed. 
It is during this phase that caspases, nucleases and other effector molecules become active. The 
execution/degradation phase is a consequence of the former phases, eventually leading to the dismantlement 
of the cell.  In multicellular organisms, an additional stage called “clearance” occurs. Clearance refers to the 
engagement of the immune system to remove the apoptotic bodies. 
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Figure 3: Apoptosis can be initiated by intracellular (intrinsic) or extracellular (extrinsic) triggers. Extrinsic or death 
receptor pathway is triggered by the binding of specific ligands to death receptors (FAS-R, TRAIL-R and TNF-R), which 
trimerize and assemble the death-inducing signaling complex (DISC). This leads to the activation of the initiator caspase, 
caspase-8 (or -10). In type I cells, cell death is the consequence of the direct activation of executioner caspases by caspase-
8 whereas in type II, cell death requires the caspase-8-mediated cleavage of the BH3-only, BID. The new form of truncated 
BID (tBID) transactivates the mitochondrial apoptotic pathway necessary for the extrinsic pathway of apoptosis. The 
intrinsic apoptotic pathway culminates with the mitochondrial outer membrane permeabilization (MOMP) and subsequent 
release of cytochrome C. Cytochrome C induces the assembly of the apoptosome (comprising APAF-1, deoxy-ATP) which 
recruits and activates the initiator caspase-9. Caspase-9, in turn, cleaves and activates the executioner caspases (-3, -6, -7). 
MOMP is regulated by pro-survival and BH3-only BCL-2 family members and executed by the pro-apoptotic effectors 
BAX and BAK. From J Cell Biol. 2001 Dec 10;155(6):1003-15. 
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2.1 Extrinsinc pathway of apoptosis 
Extrinsic apoptosis refers to a type of apoptotic cell death that is triggered in response to bacterial pathogens, 
toxins, nitric oxide, growth factors and hormones. Extrinsic apoptosis is sensed and propagated by 
transmembrane receptors, called Death Receptors (DRs).  
DRs belong to the family of tumor necrosis factor (TNF) receptor (TNF-R), a family of type II 
transmembrane proteins arranged in stable homotrimers. The TNF-R family includes 29 receptors with 
pleotropic responses, such as proliferation, inflammation, etc. Within this family, only those owing a death 
domain (DD) can elicit an extrinsic apoptotic cascade.  
More than 19 ligands are reported to interact with the DRs, but the only ones with a role in apoptotic cell 
death are tumor necrosis factor α (TNFα), the TNF-related apoptosis inducing ligand (TRAIL), FasL (also 
known as CD95L). Each ligand will bind to a specific death receptor, such as TNFα receptor 1 (TNFR1), 
TRAIL receptor (TRAIL-R) and FAS-R/CD95, respectively. Alternatively, an extrinsic apoptotic signal can 
also be elicited by “dependence receptors” such as the UNC-5 homolog family of receptors and deleted in 
colorectal cancer (DCC) family receptors, which in the absence of their ligand, netrin-1, trigger the extrinsic 
pathway 14. 
The binding of their ligand stabilizes the homotrimers of DRs, inducing a change of conformation and 
allowing the assembly of a multiprotein complex termed complex IIa or “death-inducing signaling complex” 
(DISC). Most of the ligand-bound DRs share similar activation pathways except for TNF-R1. 
2.1.1 FAS and TRAIL pathway 
Upon binding to their specific ligands, FAS-R and TRAIL-R recruit the DISC, which consists of receptor-
interacting protein kinase 1 (RIPK1), multiple isoforms of cellular FLICE-like inhibitory protein (c-FLIP) 
and a DD-containing adapter termed Fas-associated DD (FADD). Owing to the death effector domain (DED) 
of FADD, caspase-8 is recruited. The next step will be the dimerization and activation of these caspases.  
According to the subsequent involvement or not of mitochondria, cells are classified in type I and II. In type 
I cells (e.g. lymphocytes) Caspase-8 cleaves and directly activates the executioner caspases. In the case of 
type II cells (e.g. hepatocyte and pancreatic β cell), an apical caspase transactivates the mitochondrial intrinsic 
pathway by cleaving BH3-interacting domain death agonist (BID). The truncated form of BID, tBID, induces 
then mitochondria outer membrane permeabilization (MOMP) by antagonizing the anti-apoptotic BCL-2 
family members (Fig 3). Type I and type II cells seems to differ in the amount of inhibitors of apoptosis 
(IAPs) they contain 15. 
The precise contribution of caspase-10 (a close of homolog of caspase-8) in the extrinsic pathway is still a 
debatable subject. 
Notably, c-FLIP is an important regulator of this pathway. There are two variants of c-FLIP, one of 55 kDa 
and one of 26 kDa. Both FLIPs contain a DED domain but lack the caspase domain, acting as a dominant-
negative inhibitor of Caspase-8. As a consequence TNF-α, FAS and TRAIL-induced apoptosis is dampened. 
Elevated expression of c-FLIP usually promotes the activation of the NF-κB pathway, triggering cell survival 
16
. 
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2.1.2 TNF-R pathway 
TNF is a pro-inflammatory cytokine produced by immune cells and involved in human disease, in 
autoimmune disorders (e.g. Crohn’s disease, rheumatoid arthritis), neurodegeneration and cancer.  Two TNF 
receptors are reported: TNF-R1, which has a DD domain, and TNF-R2, which has not. TNF-R2 is found 
mostly in immune cells and endothelium. The TNF-R1 pathway is mostly involved in proliferation, anti-
apoptotic and pro-survival function via its main target NF-κB. There, TNF becomes an apoptotic inducer 
only if NF-κB pathway is disabled. As a consequence, in vivo, TNF-induced apoptosis has a minor role when 
compared to its inflammatory signal functions.  
Binding of TNFα to its receptor TNF-R1, triggers the formation of the complex I, which signals NF-κB 
activation. Complex I comprises TNF-R1-associated death-domain protein (TRADD), FAS-associated 
protein with a DD (FADD), receptor–interacting protein kinase 1 (RIPK1) also known as RIP1, TNF 
receptor-associated factor 2 (TRAF2) and the cellular inhibitors of apoptosis 1 (cIAP1) and cIAP2. After its 
recruitment, RIPK1 undergoes a K63-polyubiquitination by cIAPs. This fact allows the docking of a complex 
containing, transforming growth factor-β-activated kinase 1 (TAK1), TAK1 binding protein 2 (TAB2) or 
TAB3, which in turn attract the assembly of NF-κB kinase (IKK) complex. In an unstimulated context, NF-
κB dwells in the cytoplasm and its transcriptional activity is constantly inhibited by IκBs. TNFα activates 
NF-kB through the ubiquitination and clearance of IκB via the activation of IKK complex, which includes 
IKKα and IKKβ and NEMO. IKK complex phosphorilates IκBs in two serine residues, targeting them for 
ubiquitination and clearance by the ubiquitin proteasome system (UPS). Unleashed, NF-κB moves to the 
nucleus where it exerts its pro-survival transcription activity. 
 
 
Figure 4. Schematic representation of TNF-R1 signal transduction. Binding of tumour necrosis factor (TNF) to its receptor 
triggers a conformational change associated to the recruitment of the membrane-associated complex I. This complex 
comprises TRADD (a DD-containing adapter), the death domain-containing protein kinase receptor-interacting protein 1 
(RIP1) and several ubiquitin E3 ligases such as TRAF2, cIAP1 and cIAP2, and the LUBAC complex. In complex I, RIP1 
is polyubiquitinylated, mediating the recruitment and activation of TGF-beta-activated kinase 1 (TAK1) and IKB kinase 
(IKK). Phosphorylation and subsequent UPS-mediated degradation of IKB leads to the activation of  NF-κB. TAK1 is also 
able to phosphorylate and activate the MAPK pathway. 10-15 minutes later, deubiquitination of RIP1 and TRAF2 by CYLD 
or A20 brings to the assembly of complex IIa (DISC), with the subsequent caspase-8 activation and apoptosis. FLICE-
inhibitory protein (FLIP) is a negative regulator of complex IIa. See text for details. Adapted from Nat Rev Mol 
CellBiol. 2013 Nov;14(11):727-36. 
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In vitro, the apoptotic activity of TNF requires translation or transcription inhibition using either 
cycloheximide or actinomycin D, respectively 17. RIPK1 deubiquitination is essential for the switch of cell 
fate from survival to cell death. The deubiquitination of RIPK by either Cylindromatosis (CYLD) or A20 
deubiquitinases leads to a molecular rearrangement of complex I into complex IIa (Fig 4).  Deubiquitinated 
RIPK1 is reported to dissociate from the TNF-R1 complex, and starts the assembly of a multimeric complex 
comprising TRADD, FADD, pro-caspase-8 and FLICE-like inhibitory proteints (FLIPs). TRADD-dependent 
complex IIa induces the homodimerization and activation of pro-caspase 8, which in turn activates 
executioner caspases. 
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2.2 Mitochondrial or Intrinsic apoptotic pathway. 
Mitochondria are central checkpoints in the life-death decisions of most vertebrate cells. In proliferating cells, 
these organelles are the powerhouse, providing the majority of ATP within a cell, through a sophisticated 
mechanism involving the formation of an electrochemical potential across the inner mitochondrial membrane 
(IMM). This gradient is produced through an electron transport chain during the transfer of electrons from 
NADH to Oxygen, the final acceptor, pumping protons from the matrix to the inter-membrane space. The 
potential energy accumulated is then turned into ATP through an endergonic reaction catalyzed by the ATP-
synthase. 
This delicate equilibrium can be altered by certain stresses or by pharmacological treatments. As a 
consequence, mitochondria stand as a central check-point in the apoptosis induction. Intrinsic apoptotic cell 
death is induced through the mitochondria outer membrane permeabilization (MOMP) and the release of 
soluble proteins (e.g. Cytochrome c), which promote the activation of caspases and the cell dismantling. The 
induction of MOMP dissipates the mitochondrial transmembrane potential (∆ψm), altering the 
electrochemical potential produced by the Oxidative phosphorylation (OXPHOS) process, leading to a 
concomitant bioenergetics crisis. 
Intrinsic Apoptosis can be induced by different initiator signals, such as increased cytoplasmic Ca2+ 
concentration, ROS, hypoxia, growth factor deprivation and glucose starvation, chemotherapy etc. 
The mechanism of BAX/BAK-dependent mitochondrial outer membrane permeabilization (MOMP) is a key 
event in intrinsic apoptosis Therefore, Bak -/-/Bax -/- mice are resistant to the majority of mitochondrial 
apoptotic triggers. The importance of BAX and BAK during development is underscored by the high lethality 
(more than 90%) of double knock-out mice. The few mice able to survive to birth, show deficient apoptotic-
related phenotypes 18.  
The cytochrome C (cyt C) released during MOMP binds APAF-1, a scaffold protein that undergoes a 
conformational change and binds pro-caspase-9 via its caspase recruitment domain (CARD) 19. The complex 
resulting has been called apoptosome and contains multiple subunits of APAF-1, pro-caspase-9 and deoxy-
ATP. With a mechanism still controversial, the assembly of this complex activates the pro-caspase-9, which 
in turn activates the executioner caspase-3, -6 and -7 (Fig 3).  
In addition, other proteins are released from mitochondria during MOMP: the IAP Mitochondria-derived 
activator of caspases (SMAC), also known as IAP-binding mitochondrial protein (DIABLO), the serine 
protease OMI (HtrA2), the apoptosis inducing factor (AIF) and endonuclease G (EndoG).  
Some of them are well known triggers of caspase-independent forms of cell death. In vitro, caspase inhibitors, 
such as QVD-OPh or ZVAD-fmk, usually are only able to delay cell fate. In a context of inhibited caspases, 
AIF and/or Endo G can drive caspase-independent forms of death. In physiologic conditions AIF resides in 
the mitochondrial intermembrane space where it performs oxidoreductase functions, due to a FAD binding 
domain. Similarly to Cyt c, when released from mitochondria in response to apoptotic stimuli, AIF 
translocates to the nucleus to promote the large-scale (50 kb) DNA fragmentation. The translocation from 
the mitochondria to the nucleus of another endonuclease of mammalian cells called EndoG regulates the 
DNA fragmentation independent of caspases 20, 21. 
Interestingly, the MOMP-independent release of pro-apoptotic molecules from mitochondria is still possible 
under specific circumstances. This is the case of those cellular perturbations that cause a sudden increase in 
intracellular calcium levels, ROS production, following for example acute injuries such as myocardial 
infarction, stroke or during ER stress. Under these settings, mitochondria show increased inner membrane 
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permeability due to the opening of the mitochondrial permeability transition pore (MPTP). This pore is 
structurally characterized by the presence of F1Fo ATP Synthase, translocator protein (TSPO) and 
Cyclophillin-D.  In the past, ANT and Voltage Dependent Anion Channels (VDACs) were accepted proteins 
of the MPTP but genetic knock-down studies have ruled out their participation. The opening of the MPTP is 
coupled to both apoptosis and necrosis, relying on context and cell-specific cues.  
 
 
2.2.1 Regulation of MOMP 
2.2.1.1 Bcl-2 family members 
MOMP is considered the point of no return in mitochondrial apoptosis. The integrity of the outer 
mitochondrial membrane is primarily controlled by proteins belonging to the BCL-2 family 18. On a 
functional and structural basis, BCL-2 proteins can be classified in anti- and pro-apoptotic proteins. Within 
the pro-apoptotic ones, they are classically sub-divided into effectors and BH3-only proteins, though some 
authors prefer to refer them as group II and group III, respectively. 
Anti-apoptotic Bcl-2 family members. 
The anti-apoptotic proteins contain 4 conserved α-helix BCL-2 homology (BH) domains and are also referred 
to as BH1-BH4. Their C-terminal BH4 domain targets them to the cytoplasmic surface of mitochondria or 
endoplasmic reticulum. Members of this subgroup include BCL-2, BCL-XL, BCL-W, MCL-1, A1/Bfl1, 
Boo/Diva, Nrf3, and BCL-B. Their anti-apoptotic effects seem to depend especially on their capacity to 
neutralize pro-apoptotic effectors such as BAX and BAK and interacting with BH3-only polypeptides (see 
below). Additionally, in some models BCL-2 can prevent apoptosis by dampening the release of Ca2+ from 
endoplasmic reticulum (ER) stores or by increasing the antioxidant capacity of cells 22. 
Effector pro-apoptotic proteins: BAX and BAK 
BAX and BAK represent the effector pro-apoptotic proteins. This subset of proteins is responsible of the 
pore formation, which eventually leads to the MOMP. Classically, they were defined by the presence of 3 
BH domains, lacking the N-terminal BH4 domain. However, recent reports suggest they may also contain a 
BH4-like domain 23. While BAK resides in the outer mitochondrial membrane (MOM), BAX normally 
localizes in the cytoplasm. In response to an apoptotic trigger, BAX C-terminal transmembrane (TM) domain 
loses its attachment to its hydrophobic surface groove. This elicits BAX translocation and insertion into the 
outer mitochondrial membrane OMM. Next, a conformational change of the N-terminus epitope of both BAX 
and BAK is crucial for the activation of these proteins. Following this event, the exposure of a BH3 domain 
seems to be driving the oligomerization of these proteins through the interaction with the hydrophobic surface 
groove of another activated BAK or BAX. Finally, a symmetric homodimer is formed, which in turn will 
oligomerise to form a large oligomeric complex 24 (Fig 5). 
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Figure 5: Model of BAK and BAX oligomerisation and pore formation. Upon apoptotic signaling, BAX is activated and 
translocates to the mitochondria through the eversion of its transmembrane (TM) domain. The BH3 domain (red triangle) 
of BAX or BAK is exposed, allowing the formation of symmetrical BAX or BAK dimers. Eventually, the dimers homo-
oligomerise, forming a pore that induces MOMP and releases of pro-apoptotic factors. From J Cell Biol. 2001 Dec 
10;155(6):1003-15. 
  
 
Effector pro-apoptotic BCL-2 family member BAX and BAK are also reported to regulate mitochondrial 
dynamics. Mitochondrial dynamics, which comprises fission and fusion, is essential for maintaining 
mitochondrial integrity and tuning the bioenergetics status of the cell. Mitochondrial fission is regulated by 
dynamin-related protein 1 (Drp1), a large GTPase, which assembles in spirals around the OMM to induce its 
division. In its activity Drp1 is assisted by Fis1 and endophilin B (also called Bif1). Fusion is instead mediated 
by three large GTPase proteins: mitofusin (MFN) 1 and 2, in charge of OMM fusion and OPA-1, which 
mediates the internal mitochondrial membrane (IMM) fusion 25. Monomeric BAX is for example capable of 
promoting mitochondrial fusion. This function is impaired during apoptosis when BAX undergoes 
conformational changes that prompts its insertion into mitochondrial outer membranes and oligomerization. 
The mechanism by means of which BAX triggers fusion is not completely elucidated but involves the 
interaction with mitofusion-2 (MFN2) homotypic complexes at the level of mitochondria 26. 
 
BH3-only proteins. 
BH3-only proteins are a heterogeneous group of pro-apoptotic polypeptides that share a restricted sequence 
homology of around 15-amino acids (aa) within the BH3 domain. According to their pro-apoptotic 
mechanism of action, they can be further divided in two sub-groups: Activators and Sensitizers/Depressors: 
• Activators: BIM, tBID, PUMA are capable of directly inducing effector pro-apoptotic BAX and 
BAK activation, promoting their oligomerization and the cyt C release.  
 
• Sensitizers/depressors: BAD, BIK, harakiri (HKR), NOXA, BMF. This subgroup of proteins is 
unable to directly activate BAX and BAK. Their pro-apoptotic function is thought to develop by two 
possible mechanisms: sensitization or depression. Depressors neutralize the anti-apoptotic family 
members while sensitizers reduced the threshold of BAX and BAX activation, without being able to 
trigger apoptosis by themselves.  
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Figure 6: Regulation of BAX and BAK activation by a network of BCL-2 family members. a) BH3-only activators (BH3 
Act) directly activate the effector pro-apoptotic proteins (BAX and BAK), thus promoting MOMP. Their activity is 
dampened by Anti-apoptotic BCL-2 family members. BH3 Sen (sensitizer/depressor) cannot directly activate BAX and 
BAK, but only prevent the interaction with anti-apoptotic proteins or in alternative reduce the threshold for the engagement 
of BAX and BAK. b) Validated interactions between BCL-2 family members are represented by connecting lines. The 
BCL-2 homology (BH) domain structure of each BCL-2 member is illustrated. From Nat Rev Cancer. 2013 Jul;13(7):455-
65. 
 
BH3-only proteins seem to sense and respond to different types of stress, each member sensing a specific 
stimulus. BID, for example, is constitutively expressed in the cell cytoplasm where it is cleaved by caspase-
8, lysosomal cathepsins and other proteases. AKT, induced by many growth factors, inhibits the intrinsic 
pathway through the phosphorylation of BAD. Growth factors withdrawal elicit the dephosphorylation and 
activation of BAD followed by its release from the cytoplasmic 14-3-3 protein, which acts as a chaperone 
and inhibitor 27. The activation of BIM is regulated by its release from microtubules during paclitaxel 
treatment. The activation of BMF responds to the release from actin filaments after loss of attachment. Finally 
PUMA and NOXA are synthetized upon DNA damage in a p53-dependent manner. The complex interactions 
between proteins of Bcl-2 family are depicted in Fig. 6. 
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2.2.1.2 P53 
P53 has been termed the “cellular gatekeeper” and “the guardian of the genome”, because of its pivotal role 
in controlling the cell response to different stress. Adverse conditions activating p53 include for example, 
DNA damage, oxidative stress, virus infection, heat shock, ribonucleotide depletion and a variety of 
oncogenic proteins (eg. MYC, RAS, adenovirus E1A and β-catenin). By means of its transcriptional and non-
transcriptional activity, p53 controls cell cycle, DNA repair, senescence, cell death and autophagy, overall 
functioning as a key tumor suppressor. p53 is inactivated in more than 50% of solid tumors by either direct 
mutation (which most often occur in the DNA binding domain) or mutation of upstream activators such as, 
Ataxia telangiectasia mutated (ATM) and check point kinase 1 (CHK1) or by amplification of the Mouse 
double minute 2 homolog gene (MDM2).28 
p53 is structurally characterized by a N-terminus transactivation domain (TAD), which can be further 
subdivided in TAD1 and TAD2, a core DNA binding domain (DBD), a tetramerization domain, which is 
essential for p53 activity in vivo and a C-terminus regulatory domain. 
The complex p53 regulatory network allows the modulation and expression of a specific subset of target 
genes, with a fine-tune response to various stresses. p53 is stabilized (and thus activated) through a series of 
post-translation modifications or by altering its interaction with MDM2. 
Phosphorylation is the most relevant p53 modification carried out by several kinases, such as ATM, 
CHK1/CHK2, c-Jun N-terminal kinase (JNK) and p38. Acetylation, methylation, sumoylation and 
neddylation, have been also associated with the regulation of p53 and its binding to DNA. 
MDM-2 is a crucial regulator of p53 content. In undamaged cells, p53 is present at low concentrations and it 
is usually cleared by the proteosome via its interaction with MDM2, a RING finger E3 ubiquitin ligase. The 
ubiquitination sites concentrate specifically at the p53 tetramerization and C-terminus domains. MDM2-p53 
interaction can also be modulated by phosphorylation/acetylation of MDM2 or by the activity of ARF (also 
termed p14ARF), specially under oncogenic stress. Excess activity of several oncoproteins leads to a strong 
induction of the tumor suppressor ARF. ARF protein arises from the alternative reading frame of INK4A/ARF 
locus and is described to interfere with MDM2-p53 interaction, thus stabilizing p53. Interestingly, MDM2 is 
itself a target gene of p53, generating an auto-regulatory negative feed-back loop.  
p53 is crucial in the life and death decision. According to the magnitude of an insult, it can either trigger cell 
cycle arrest through induction of p21 and the engagement of DNA repair mechanisms or alternatively, elicit 
different types of cell death (Fig. 7). If focusing on apoptosis, p53 elicits this form of cell death through 
transcriptional and non-transcriptional mechanisms. 
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Figure 7:  Role of p53 in apoptosis and necrosis. p53 can contribute to apoptosis in a transcriptional and non-transcriptional 
fashion. Nuclear p53 induces the transcription of pro-apoptotic BCL-2 family members, such as PUMA, NOXA and BAX. 
Alternatively, p53 is able to activate BAX insertion to the mitochondrial membrane. Cytoplasmic p53 is held inactive by 
BCL-XL. Translocation to the mitochondria is followed by the oligomerisation of Bax, antagonizing the anti-apoptotic BCL-
2 and BCL-XL proteins. p53 can trigger necrosis through the interaction with Cyclophillin D, causing the opening of 
mitochondrial permeability transition pore (MPTP). From Discov Med. 2010 Feb; 9(45):145-52. 
The contribution of p53 to apoptosis is mostly due to its transcriptional activity. Activated p53 moves to the 
nucleus where it induces the transcription of a battery of pro-apoptotic genes, for example PUMA, NOXA, 
BAX, which in turn induce or promote mitochondrial apoptosis. Data obtained from knock-out models have 
been decisive to prove that PUMA and NOXA are necessary for p53-mediated apoptosis. Pro-apoptotic 
functions of p53 can be reached through the repression of anti-apoptotic genes, such as the IAP, survivin. 
p53 can also trigger apoptosis in a transcription-independent manner. A stress-stabilized pool of cytoplasmic 
p53 is the major source of p53 available for the mitochondrial translocation. Nonetheless it is still debatable 
how this p53 pool is generated.  At the level of mitochondria, p53 can induce apoptosis by triggering the 
oligomerization of BAX and BAK or by dampening the anti-apoptotic BCL-2 family members, BCL-XL and 
BCL-2. 
 
2.2.1.3 IAPs 
The mitochondrial pathway can still be regulated downstream of the apoptosome through the inhibitor of 
apoptosis (IAP) family. IAPs are an evolutionary conserved family of proteins that contains 8 members in 
humans (Survivin, XIAP, cIAP1, cIAP2, ML-IAP/livin, Apollon/BRUCE, NAIP and ILP-2). Members of 
this family are characterized by the presence of at least one copy of the BIR (baculovirus IAP repeat) domain, 
a zinc-binding fold that is necessary for their anti-apoptotic function. The number of BIR repeats is crucial 
to determine their binding partners. XIAP, one of the most well-known IAP, possesses 3 BIR domains and 
can target either caspase-3, -7 or -9, while Survivin, with only one copy, can only associate with caspase-9. 
IAPs are over-expressed in many cancers and are important for tumor cell survival since they participate into 
chemotherapy resistance 29. IAPs function also as E3 ligases: cIAP1 and 2 are involved in the signal 
transduction of the NF-κB in extrinsic apoptosis. 
  
33 
 
3 Necrosis: Accidental versus Regulated necrosis 
Necrosis derives from “nekros”, the Greek term for corpse. For two decades, necrosis has been considered 
only a mere accidental and unregulated cell death subroutine, caused by the action of an extremely harsh 
chemical, physical or mechanic insult 2. Morphologically, necrosis has been characterized by a generalized 
swelling of the cytoplasm, which acquires a translucent aspect, and organelles (oncosis), as well as some 
atypical alterations of the DNA (condensation into small and irregular patches), the dilatation of the nuclear 
membrane, the rounding of the cell and eventually, the plasma membrane rupture. In addition, this subroutine 
of cell death can be differentiated from apoptosis by the absence of cellular fragmentation. Notably, the 
apoptotic corpses generated during this fragmentation will finally undergo a membrane rupture, process 
known as secondary necrosis and explained by the absence of phagocytic system in vitro. 
 
 
Figure 8. Schematic view of regulated-necrosis. Different types of triggers can induce regulated necrosis (level 1) by means of specific 
initiators (level 2). The main regulated necrosis initiators are PARP1 hyperactivation, mitochondrial permeability transition (MPT) pore, 
Cys/Gu antiporter, Necrosome, NADPH oxidases and inflammasome. For each initiator, colored arrows indicates the intracellular 
mediators (level 3). Intracellular mediators of necrosis comprise NAD+ and ATP-depletion, Ca2+ overload, dysregulation of the redox 
status, increased production of reactive oxygen species (ROS) and the activity of phospholipases. This complex network of mediators 
eventually leads to the activation of necrosis executioners (level 4) leading to the energetic catastrophe, lipid peroxidation, lysosomal 
membrane permeabilization (LMP) and osmotic swelling. See text for details. Pharmacological inhibitors are depicted. Abbreviations: 3-
AB, 3-aminobenzamide; CsA, cyclosporin A; DFO, deferoxamine; DPI, diphenylen iodonium; FER1, ferrostatin 1; fMLP, N-formylated 
methionyl-leucyl-Phe; GKT, GKT137831 (an NADPH oxidase 1 and NADPH-oxidase 4 inhibitor; Genkyotex); IFNAR, IFNα/β receptor; 
IRI, ischaemia–reperfusion injury; LPS, lipopolysaccha- ride; MNNG, N-methyl-Nʹ-nitro-N-nitrosoguanidine; NEC1s, more specific and 
stable variant of necrostatin 1; NLR, NOD-like receptor; PJ-34, an inhibitor of poly(ADP-ribose) polymerase; PMA, phorbol-12-myristate- 
13-acetate; RIG-I, retinoic acid-inducible gene 1; RLR, SfA, sanglifehrin A; TLR, Toll-like receptor; TNFR, tumour necrosis factor 
receptor; TRAILR, TNF-related apoptosis-inducing ligand receptor; UV, ultraviolet light; VX-740, a caspas e 1 inhibitor. Figure adapted 
from Nat Rev Mol Cell Biol. 2014 Feb;15(2):135-47 
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After the discovery of the RIPK1/RIPK3-mediated necroptosis, the concept of regulated necrosis was 
introduced to define a series of necrotic cell death modalities genetically modulated, which rely on controlled 
biochemical events. Regulated necrosis has a prominent role in multiple physiological and pathological 
settings, such as ischemia reperfusion injury (IRI), diabetes, neurodegeneration, heart failure, infections and 
cancer 30.  
Several forms of regulated necrosis have been reported: Necroptosis, Parthanatos, CYPD-mediated necrosis, 
Ferroptosis, NETosis, Pyroptosis. Although each subroutine is initiated by specific triggers, the cascade of 
biochemical mediators and executioners involved are partly shared. NAD+ and ATP depletion, pathological 
ROS production, a failure in the Ca2+ homeostasis, activation of proteases or lysosomal membrane 
permeabilization (LMP), are key events in regulated necrosis. A schematic view of regulated necrosis 
biochemical events is depicted in Fig 8. 
 
3.1 Mediators of Regulated Necrosis 
3.1.1 NAD+ and ATP depletion 
Nicotinamide adenine dinucleotide (NAD) is an essential reducing equivalent that exists under two forms: 
the oxidized form NAD+ and the reduced form NADH. NADH can be generated in the cytoplasm during the 
glycolysis and in mitochondria, as a product of the tricarboxylic acid (TCA) cycle, together with reduced 
Flavin adenine dinucleotide (FADH). The reducing equivalents brought by NADH and FADH enter into the 
electron respiratory chain and are, in turn, used by the mitochondrial oxidative phosphorylation 
(OXPHOS) pathway to generate ATP. NAD+ depletion is a relevant mediator of regulated necrosis modalities 
and reported to occur in Parthanatos and CYPD-mediated necrosis 30. At the cytoplasmic level, NAD+ 
depletion leads to an interruption of the glycolytic flow.  In an attempt to reestablish the NADH levels, ATP 
is used to generate NAD+, thus depleting the internal stores of ATP. The mitochondrial NAD+ pool 
withdrawal is one of the most detrimental outcomes of the MPTP opening, leading to the blockage of the 
OXPHOS 31.   
Alternatively, a decrease of ATP can occur as consequence of the dissipation of the mitochondrial 
transmembrane potential (∆ψm), leading to the subsequent bioenergetic catastrophe. Depletion of ATP is 
documented in both apoptosis and necrosis. However, levels of ATP during apoptosis do not drop as abruptly 
as in necrosis. One explanation to this fact would be the caspase-dependent disruption of ATP-consuming 
processes, such as PARP-1 activity, the protein translation and the ubiquitin-proteasome system (UPS) 32. In 
conclusion, the final decision to undergo necrotic or apoptotic cell death, could be determined by the 
bioenergetic status and the effective caspase/endonuclease activation.33 
  
35 
 
3.1.2 ROS 
Reactive oxygen species (ROS) are highly reactive molecules containing oxygen. ROS serve as signaling 
molecules to regulate physiological processes, but are also involved in different pathological conditions, such 
as aging, neurodegeneration, diabetes, atherosclerosis and cancer 34. 
One of the main intracellular sources of ROS is the electron rich environment of mitochondrial inner 
membrane (IMM) during OXPHOS. Among the electron complexes, complex I and III are known to possess 
the highest ROS-producing capacity. On the other hand, the mitochondrial respiratory chain is a relevant 
target for the damaging effects of ROS 35. Several extra-mitochondrial sources of ROS have been also 
documented, for instance, through the activation of a broad family of NADPH oxidases (NOXs) mainly 
located at the plasma membrane, through glycolysis and production of advanced glycation end products 
(AGEs), etc 32.  
Most intracellular ROS are derived from the anion superoxide (O2•−), which is produced by one-electron 
reduction of O2. O2•− is converted by the mitochondrial superoxide dismutase (SOD) into H2O2. Both O2•− and 
H2O2 can then be converted into the highly reactive hydroxyl radical (OH•), by Haber-Weiss and Fenton 
reaction, respectively. 
Excessive ROS production is scavenged by the cooperation of endogenous and exogenous as well as 
enzymatic and non-enzymatic, antioxidant systems. An imbalance between ROS generation and the 
scavenger machinery leads oxidative stress. Oxidative stress is enhanced by conditions where there is an 
increased electron flow through the respiratory chain (e.g. organ reperfusion after ischemic episodes) or by 
depletion of antioxidants (e.g. GSH). Oxidative stress ultimately leads to cell demise, that can resolve either 
into an apoptotic or necrotic subroutines of cell death 36. 
 
Three are the main biological targets of ROS: proteins, nucleic acids and lipids. ROS attacks thiol groups (-
SH) present in polypeptides, modifying and altering their conformation and function. Similarly, ROS is 
reported to affect the Ca2+ homeostasis, altering the Ca2+ channels of ER and the plasma membrane. In the 
same line, the oxidation of the adenine nucleotide translocase (ANT) by ROS facilitates the opening of MPTP 
37
. 
DNA is particularly susceptible to oxidative damage. Genomic DNA damage activates a series of DNA 
damage response (DDR) pathways governed by master regulators, such as p53 or PARP-1, which in turn 
participate into the commitment into cell death or survival.  
Another important target of ROS oxidative activity are the polyunsaturated fatty acids (PUFAs) present in 
cellular membranes. Lipid peroxidation of PUFAs leads to the formation of reactive aldehydes (e.g. 4-
hydroxynonenal), which can destabilize the integrity of both plasma and organelles membranes. In addition, 
lipid peroxidation and plasma membrane disruption can be the consequence of cytosolic phospholipase A2  
and Lipoxygenase (LOX) activation 38. 
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3.1.3 Calcium 
Ca2+ is an important signal mediator controlling different cellular processes such as gene transcription, 
muscle contraction and cell proliferation. Viable cells maintain the calcium gradient across plasma membrane 
mainly through the Na+/Ca2+ exchanger (NCX) and the plasmatic Ca2+ pump (PMCA), also called Ca2+ 
ATPase. As a consequence of this ATP-dependent process, extracellular calcium concentration is ∼10 folds 
higher than in the intracellular compartments. Most of intracellular calcium is stored in the ER by means of 
the sarco/endoplasmic reticulum Ca2+ ATPase (SERCA). It is released back to the cytoplasm through 
ryanodine (RyR) and inositol-1,4,5-trisphosphate receptors (Ins(1,4,5)P3R). Like many other mediators, 
cytosolic calcium spikes may trigger either apoptosis or necrosis, and the specific cell fate subroutine engaged 
seems to depend on the severity of the concentration increase.39 
Failure of Ca2+ homeostasis in necrosis has two main consequences: Ca2+ mitochondrial overload and 
activation of Ca2+-dependent proteases. Ca2+ mitochondrial overload is responsible of the stimulation of the 
TCA cycle with a subsequent enhancement of electron flow leading to ROS overproduction. This effect is 
due to the Ca2+-mediated positive regulation of enzymes such pyruvate dehydrogenase, NAD+-dependent 
isocitrate dehydrogenase, and 2-oxoglutarate dehydrogenase. At the mitochondria level, in addition, Ca2+ 
boost is described to induce the opening of the MPTP. On the other hand, the increase of Calcium activates 
Ca2+-dependent proteases, especially calpains, which cleave and inactivate NCX. This process will be 
sustaining an intracellular Ca2+ increase and, finally,  the destabilization of the lysosomal membrane leading 
to the lysosomal membrane permeabilization (LMP) (see below).  
 
3.1.4 Lysosome and LMP  
Under physiological conditions, lysosomes are fundamental organelles for degradation of a plethora of 
molecules and biological structures. The lysosome has also emerged as a significant hub of the cell death 
machinery. LMP and the subsequent extra-lysosomal release of hydrolases are reported events in both 
apoptosis and necrosis initiated in extra-lysosomal sites. However, the lysosome, its hydrolases and its 
elevated oxidative potential are enabling the capacity of the lysosome to act as a cell death initiator organelle. 
Lysosomal membrane integrity is preserved through the action of a series of cytoprotective factors. Serpins, 
a family of protease inhibitors, are able to block LMP through the inhibition of cathepsins. Similarly, another 
relevant factor is HSP70. HSP70 localization and association to the lysosomes makes them less prone to 
LMP. In the same line, HSP70 is reported to delay TNF, heat shock and oxidative stress-driven necrotic cell 
death.32 LMP occurs as a response to a variety of stimuli such as ROS-dependent membrane permeabilization 
or the activation of two lysosomal lipases, the acid sphingomyelinase (A-SMase) or acid ceramidase (A-
CDase). The lysosomal enzyme A-SMase converts the membrane lipid sphingomyelin into ceramide, which 
in turn can be further converted into sphingosine by the A-CDase. While ceramide has shown to block 
mitochondrial respiratory chain complex III, the lysosomotropic sphingosine, can permeabilize the cell 
membrane through its detergent-like properties 40. 
The intraluminal lysosomal compartment is rich in H2O2, reduced iron ions (Fe2+) and reducing equivalents, 
being the perfect microenvironment for the Fenton reaction. It contains desferrioxamine, an iron chelator, 
which is reported to prevent the lipid peroxidation and the LMP induced by oxidative stress 32. 
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3.2 Subroutines of Regulated necrosis 
3.2.1 Necroptosis 
Necroptosis is a necrotic cell death modality initially described in L929 cells treated with TNF-α after 
pharmacologically inhibiting caspases. The NCCD 2015 defines Necroptosis as a RCD subroutine that 
critically depends on the kinase activity of RIPK1 -inhibited pharmacologically by necrostatin-1-, RIPK3 
and on the execution by mixed lineage kinase domain-like (MLKL) -inhibited by necrosulfonamide- 2. 
Death receptor-mediated apoptosis and necroptosis are interconnected subroutines of cell death but mutually 
exclusive. RIPK1 plays an important role in both the transduction of apoptotic extrinsic pathway and also, in 
necroptosis.   
Necroptosis can be triggered by several insults, including alkylating DNA damage, exitotoxins and ligand 
DRs (TNFα, FasL and TRAIL), but also by anticancer drugs such Shikonin and GX15-070 (Obatoclax). In 
vivo, necroptosis has been reported to occur in the absence of caspase inhibition during myocardial infarction, 
ischemic or traumatic brain injury, renal ischemia-reperfusion injury (IRI) but also during the systemic 
inflammatory syndrome in the liver and immune cells 30.  
The induction of necroptosis shares several steps with the TNF-α signaling pathway (Fig 9). TNF-α 
transduces a plethora of different signals: canonical and non-canonical NF-κB activation (complex I) and 
DISC-mediated caspase-8 activation (complex IIa). In the context of an inhibited caspase-8 and after TNF-α 
exposition, RIPK1 docks a microfilament-like complex termed necrosome, which comprises RIPK1, RIPK3, 
FADD and TRADD. 
Necroptosis can be activated also in absence of TNF-α with the formation of a TRADD-independent complex 
termed Ripoptosome (also called complex IIb), which comprises RIPK1, RIPK3, FADD and FLIP-L/-
caspase-8
 
heterodimers. Ripoptosome assemble occurs under genotixic stress and critically depends on the 
autodegradation of IAPs, a process enhanced by the release of SMAC/DIABLO. Ripoptosome assembly 
stimulates caspase-8 activation and/or necroptosis, depending on cellular context. 
Caspase-8 and FLIP-L are negative regulators of necrosome and ripoptosome assemblies. Active caspase-8 
and the heterodimer caspase-8/FLIP-L are reported to cleave RIPK1 and RIPK3, as well as CYLD, preventing 
RIP1K and RIPK3 activation. Interestingly, some specific form of necroptosis RIKP1-independent but 
RIPK3-dependents has been reported 41. 
In order to get active RIPK1 and RIPK3 undergo reciprocal auto- and trans-phosphorilation. The 
phosphorylation of RIPK3 at Ser227 and 232 is essential for the subsequent recruitment of Mixed lineage 
kinase domain like (MLKL), the final executioner of necroptosis. MLKL contains a N-terminus four α-helix 
bundle (the functional domain of MLKL) connected to the C-terminus kinase-like domain by two α-helix 
linker. In normal conditions, MLKL dwells in the cytoplasm as a monomer. When RIPK3 is engaged and 
activated within the necrosome, it induces the phosphorylation of MLKL at Thr357 and Ser358 sites, which 
destabilizes MLKL, allowing its homo-oligomerization and subsequent binding to phosphatidylinositol 
phosphate lipids (PIPs) and the mitochondria-specific phospholipid, cardiolipin (CL). The interaction of 
MLKL with PIP- or CL-enriched membranes is indispensable for MLKL-dependent necroptosis.  
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Figure 9: Necroptosis signaling pathway. a) CYLD- or A20-dependent deubiquitination of RIP1 allows its dissociation from complex I 
and the assembly of complex IIa (DISC). Complex IIa is a requisite for caspase-8 activation and the induction of extrinsic apoptosis. 
Activated caspase-8 cleaves RIP1 and RIP3 blocking necroptosis. b) When caspase-8 is inhibited, RIP1 and RIP3 aggregate under the 
form of a micro-filament like complex (Necrosome), triggering MLKL-dependent necroptosis. In cells subjected to a genotoxic stress or 
IAPs depletion, the ripoptosome complex is assembled in a TNF-independent manner. According to the presence or absence of active 
caspase-8, ripoptosome can trigger either apoptotic or necroptotic cell death. Adapted from Cell Death Differ. 2015 Apr;22(4):526-39.  
 
MLKL translocates to the plasma membrane via its interaction with PI(4)P and PI(4,5)P2. At this level, 
MLKL is reported to induce an intracellular Ca2+ spike through activation of TRPM7 (a non-voltage-sensitive 
ion channel) and Na2+ influx, which potentially contribute to the necrotic phenotype. During necrosis, CL, 
which normally resides in the inner membrane is exposed to MLKL. MLKL is reported to trigger 
mitochondria-dependent ROS generation and mitochondrial fusion, the latter through the activation of 
PGAM5 phosphatase, which dephosphorilates and inactivates Drp1, a dynamin-related GTPase necessary 
for mitochondrial fission. 
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3.2.2 Parthanatos  
Parthanatos is a form of cell death characterized by the overactivation of poly(ADP-ribose) polymerase 
1(PARP-1) and the PAR-dependent release of AIF from mitochondria. The term parthanatos was coined to 
describe this death modality, combining the word PAR and Thanatos, the personification of Death in Greek 
mythology.  
The uniqueness of parthanatos makes its definition controversial since some authors define it as a form of 
caspase-independent cell death, while others a form of regulated necrosis. Indeed, parthanatos morphological 
traits are partly overlapping between apoptosis and necrosis. Morphologically, parthanatos is characterized 
by plasma membrane rupture, large scale DNA fragmentation (50 kDa), while organelles swelling is not 
reported 42. 
In physiological conditions, PARP-1 is involved in the preservation of genomic stability and it is part of the 
DNA damage response (DDR). It mainly functions as a sensor of single-strand DNA breaks (SSB). When a 
DNA SSB occurs, PARP-1 binds to the damaged DNA and its activation leads to a NAD-dependent 
PARylation of chromatin proteins surrounding the DNA breaks, which in turn signals and activates multiple 
repair enzymes such as DNA topoisomerases, helicases and ligases.  
Parthanatos is triggered by several DNA damage triggers such as alkylating agents (MNNG), ROS, increase 
of Ca2+ concentration.  In situation of profound DNA damage, hyper production of PAR causes cell demise. 
The mechanism involved it is not completely clarified, but involves the decrease of NAD+ and ATP 
subsequent to PARP-1 enzymatic hyperactivity and the interaction of PAR with AIF. PAR induces AIF 
release but also activates calpains, which in turn, generate truncated AIF (tAIF). tAIF, through a non-
specified endonuclease, cleaves DNA engaging a positive feedback loop for PARP-1 activation 42. 
3.2.3 CYPD-dependent regulated necrosis 
The aperture of MPT pore can lead to either apoptosis or regulated necrosis 36. As described before, MPTP 
is a dynamic complex whose composition has not completely been addressed. CYPD is a prominent regulator 
of MPTP, which is inhibited by cyclosporin A (CsA). CYPD-dependent regulated necrosis, is triggered by 
IRI, stroke, myocardial infarction, ROS, thapsigargin, and Ca2+ boost. The necrotic cell death due to the 
opening of the MPTP results from the loss of mitochondrial potential and subsequent decrease of ATP and 
release of mitochondrial NAD+, which in turn causes glycolysis inhibition.  
More recently, p53 has been reported as a regulator of CYPD-mediated necrosis in ischemic tissues. Upon 
H2O2 treatment, MEFs Bax-/-/Bak-/- (DKO) and WTs undergo a necrotic cell death characterized by p53 
mitochondrial accumulation and its interaction with CYPD. Genetic ablation of p53 or treatment with CsA 
is able to rescue both DKO and WT MEFs cell from H2O2-induced necrotic cell death 43. 
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3.2.4 Ferroptosis and Oxytosis  
Ferroptosis and oxytosis remain two controversial cell death modalities. Considered by some authors as a 
form of regulated necrosis, others hold them as unique subroutine entities.  
Ferroptosis and Oxytosis both depend on the Xc–Cys/Glu antiporter and a subsequent decrease of 
Glutathione (GSH). In physiological settings, Xc–Cys/Glu antiporter is responsible of the exchange between 
L-Cys and intracellular L-Glu across the plasma membrane, which is necessary for GSH synthesis.  
Ferroptosis was firstly described in RAS-transformed tumor cells lines treated with erastin, an inhibitor of 
Xc–Cys/Glu antiporter 44. Fenton-like reactions and NOX-1-dependent ROS generation are the main drivers 
of ferroptosis, which is in addition strictly depends on iron. In this setting, GSH depletion leads to the loss 
of function of GSH peroxidase 4 (GPX4) with a ROS increase and the subsequent lipid peroxidation.  
In the case of oxytosis, the depletion of GSH activates 12 and 15-lypoxygenase (LOX12,  LOX 15), which 
in turn, mediate mitochondrial-dependent ROS production and increase of cGMP. cGMP opens a cGMP-
gate channel with an increase of Ca2+, activation of calpains and LMP. 
3.2.5 NETosis 
NEtosis is a form of regulated necrosis typically observed in neutrophils as an anti-bacterial immune 
response. This cell death modality is characterized by the release of neutrophil chromatin, thus constructing 
adhesive and deadly extracellular traps (NETs) for bacteria. NOX-1 activation, which can contribute also to 
other necrotic modalities, is the main molecular event in the execution of NETosis. 
3.2.6 Pyroptosis 
The term Pyroptosis was introduced to describe a cell death subroutine engaged by macrophage infected with 
Salmonella enterica.45 Pyroptosis is part of the antibacterial innate immune defense and it is characterized 
by rapid release of cytosolic contents following the caspase-1-dependent formation of plasmatic pores. 
Several initiators of pyroptosis have been reported, including toll-like receptors (TLRs), NOD-like receptors 
(NLRs), exposure of microbial pathogen-associated molecular pattern (PAMPs), endogenous damage-
associated molecular pattern (DAMPs), ultraviolet B (UVB) irradiatiaons.30 These triggers induce the 
assembly of the inflammasome, which comprises caspase-1 (whose activation requires in some settings 
caspase-11), NLR family, pyrin domain containing 1 (NLRP1), NLRP3 and apoptosis associated speck-like 
protein containing a CARD domain (ASC). Caspase-1 induces the activation and release of its two main 
targets, IL-1β and IL-18 and the subsequent amplification of the inflammatory damage.  
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4 Autophagic cell death (ACD) 
The most updated definition of “autophagic cell death” by the NCCD claims that is a cell death subroutine 
limited or delayed by pharmacologic or genetic interventions targeting at least two distinct components of 
the molecular machinery of autophagy 2 and accompanied by the presence of an active autophagic flux.  
Studies in model organisms, such as Dictyostelium Discoideum, C. elegans and Drosophila melanogaster, 
have provided multiple evidences regarding the participation of autophagic cell death in the development of 
these organisms. However, no clear prove exists of its role in mammalian embryogenesis until perinatal 
stages 46. 
The autophagy-driven cell death is integrated in a cell death network where autophagy activity is intertwined 
with other cell death modalities. This might add a level of complication to the studies of autophagic cell death 
during the development of the aforementioned organisms. For instance, the single disruption of apoptosis or 
autophagy in C. elegans has no lethal effect for a normal development and does not result in early embryonic 
lethality 47, probably owing to compensatory mechanisms. On the contrary, the disruption of both processes 
unables these compensatory pathways and triggers massive cell death.                                                                                                                                      
A unique model to address if autophagy is indeed a cell death or survival mechanism comes from the amoeba 
Dictyostelium Discoideum, which lacks from the apoptotic machinery. In the presence of abundant nutrients, 
D. Discoideum exists in a vegetative state. Upon starvation, the amoebas aggregate in a multicellular fruiting 
body, in a process that requires PCD. While autophagy is normally engaged upon starvation, a second signal, 
the differentiation inducing factor-1 (DIF-1) is required for cells to undergo PCD by autophagic cell death 
48
. 
Drosophila melanogaster is another model organism to examine the role of autophagic cell death in a 
developmental context. During the Drosophila life cycle from larval to adult stage, obsoleted tissues, such 
as midgut and salivary glands are removed through PCD. While the removal of salivary glands seem to rely 
on parallel activity of apoptosis and autophagy, apoptosis seems dispensable in the case of midgut regression. 
Interestingly, the components of the autophagic pathway involved in PCD seem to not be completely 
overlapping with the ones required for starvation-induced autophagy 49. 
Putting aside the development models, autophagy-driven cell death has been reported in mammalian adult 
cells cultures. In most cases, inactivation of apoptosis was a requisite to observe autophagic cell death. This 
is the case of double knockout Bax-/- /Bak -/- MEFs, that subjected to long-term treatment with etoposide or 
staurosporine, undergo 3-MA-sensitive and Beclin-1 and Atg5-dependent cell death 50. Similarly, cell death 
by caspase-8 inhibition in mouse L929 cells was suppressed knocking-down Beclin-1 or Atg7. Further 
investigations proved that the specific degradation of the anti-oxidant catalase into the autophagolysosomes 
and the ensuing accumulation of ROS were at the cause of the observed caspase-independent cell death 51.  
Alternatively, in other models, the suppression of caspase activity is not necessary. Forced expression of H-
RAS in human ovarian surface epithelial (HOSE) cells causes a caspase-independent cell death and massive 
induction of autophagy. RAS-induced death relies on the induction of NOXA and Beclin-1. In the presence 
of NOXA, Beclin-1 dissociates from MCL-1, resulting in the promotion of autophagy. The genetic ablation 
of ATG5 and ATG7, Beclin-1 and NOXA is able to rescue from cell death 52. 
Basal levels of caspase-10 activity regulate autophagy of myeloma cell lines, through the proteolysis of 
BCLAF1. When caspase-10 is inhibited, BCLAF1 is stabilized and displaces BCL-2 from Beclin-1, thus 
inducing autophagy. The inhibition of caspase-10 leads to a form of autophagic cell death, which is abrogated 
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by the genetic ablation of components of the autophagy machinery (ATG5 and Beclin-1) and the knockdown 
of BCLAF1 53. 
Autosis represents a recently described autophagic cell death paradigm. Curiously, autosis occurs in cultures 
treated with autophagy-promoting peptides and in vivo models of ischemia-reperfusion. Beclin-1-derived 
peptide (Tat-Beclin-1) is a strong promoter of autosis, which is blocked by either the pharmacologic or 
genetic inhibition of autophagy. Ultrastructurally, Tat-Beclin-1 cell death is characterized by rapid shrinkage 
of the nucleus with a portion of its surface becoming concave, followed by the focal membrane rupture. By 
means of a 5000 compounds screening, the plasma membrane Na2+/K+-ATPase was identified as a key player 
in autosis. Another unique feature of autosis is represented by an increased substrate adherence of dying cells 
which could be explained by the role of Na2+/K+-ATPase in cell-adhesion 54. In vitro, autosis could be 
engaged for example, by the subpopulation with the highest level of autophagy, which therefore become 
substrate-adherent during nutrient starvation 55. The authors reported also a retroactive form of autosis 
triggered by another autophagy-inducing peptide, Tat-Flip α2, which acts by releasing ATG3 from c-FLIP 
56
. 
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5  Homeostatic Quality control mechanisms 
Eukaryotic cells possess specific mechanisms for quality control of proteins and organelles. Globally, these 
mechanisms are part of an internal homeostat. The molecular chaperones are the frontline machinery in 
charge of protein folding/refolding and sequestration of abnormal proteins, while the ubiquitin protein system 
(UPS) and the lysosomal-autophagy system are the two main intracellular degradative machineries.  
5.1  Molecular chaperones 
Conditions of inefficient or increased translation as well as expression of mutant forms of proteins are the 
main causes of unfolded proteins accumulation 57. Cancer cells synthetize a large amount of proteins to cope 
with their high proliferative and metabolic rate and are thus, extremely prone to proteotoxicity. As a 
consequence, elevated expression of individual heat shock proteins (HSPs) and the heat shock transcription 
factor 1 (HSF-1), have been reported in a wide array of human cancers, leading to the concept of non-
oncogenic cancer addiction 58. Accordingly, HSF1 and HSP70 are reported to be necessary for the survival 
and growth of several types of cancer cells, but dispensable for normal ones.  
Protein misfolding is sensed by compartment-specific stress response pathways in order to preserve 
proteohomestasis. These mechanisms include for example, the ER unfolded protein response (UPRER) and 
the cytoplasmic heat-shock response (HSR) 59. 
UPRER responds to an accumulation of unfolded protein in the ER. ER stress occurs when the unfolded 
proteins rate formation exceeds the buffering capacity of the ER folding machinery. ER stress activates three 
signaling pathways: inositol-requiring protein 1 (IRE1), protein kinase RNA-like ER kinase (PERK), and 
activating transcription factor 6 (ATF6). The UPRER is triggered by the direct interaction with unfolded 
proteins or the stress-dependent displacement of BiP/GRP78 (an HSP70 family member protein). The three 
activated branches have direct or indirect transcriptional effects, which determine upregulation of 
chaperones, increased efficiency of membrane trafficking pathways, induction of autophagy and genes 
involved in protein degradation, such as the ER-associated protein degradation (ERAD). During prolonged 
or severe ER stress, the upregulation of apoptotic genes, like for instance CHOP, triggers apoptotic cell death. 
The HSR response is rapidly induced by stresses, such as heat shock. HSF-1 is the master regulator of HSR 
and is maintained in an inactivated state by the interaction with HSP90, HSP70 and the cofactor HSP40. 
With the appearance of misfolded proteins, HSF-1 dissociates from HSPs, forming a homotrimer that 
translocates to the nucleus where it induces the transcription of chaperones, proteasome subunits and proteins 
that facilitate trafficking genes 60.  
HSC70/HSP70 and HSP90 molecular chaperones are the two major cytosolic folding machinery responsible 
of HSR. In the cytoplasm, chaperone-mediated proteostasis involves several strategies: re-folding, 
degradation or the sequestration of the misfolded proteins 57 (Fig. 10).  
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Figure 10: Strategies of protein homeostasis. In a process assisted by molecular chaperones, misfolded proteins can be 
refolded, degraded, or sequestered. Risks and benefits of each strategy are illustrated. Cold Spring Harb Perspect 
Biol. 2011 Aug 1;3(8):a004374. 
HSC70 is a protein constitutively expressed at low level in viable cells, functioning as a basal housekeeping 
chaperone. HSP70 is the main stress-inducible chaperone and it constitutes a central hub within the chaperone 
system. Finally, the remaining members of the family are involved in sensing misfolded proteins in specific 
compartments, like for example HSP70-5 (also known as BiP or Grp78) in the ER and HSP70-9 in the 
mitochondrion 61. 
In eukaryotes, HSP90 activity is essential in unstressed condition. HSP90 is required for assisting in the 
folding of a wide number of client proteins. More than 200 proteins are HSP90 “clients”, a list that includes 
protein kinases, transcription factors (e.g. p53) and steroid hormone receptors (SHRs) 62. 
HSP70 and HSP90 are induced upon accumulation of misfolded proteins in the cytoplasm. HSP70/HSP90-
driven folding of polypeptides is an ATP-dependent mechanism. Some client proteins are directly folded by 
HSP70, while in other cases, HSP70 acts like an obligate HSP90 co-chaperone. Both HSP70 and HSP90 
exert their refolding activity undergoing cycles of ATP/ADP conformational changes. Co-factors like 
HSP40, regulate the HSP70 activity through the control of the ATP hydrolysis step. The mechanism of 
refolding requires cycles of chaperone-bound and –free states, until the misfolded polypeptide has reached 
the native conformation. (Fig. 11) 
 
Figure 11: The Hsp70 cycle of refolding. (I) Hsp40 mediates the delivery of misfolded (or nascent) protein to ATP-bound 
Hsp70; (II) Hsp70 conformational change upon hydrolysis of ATP to ADP. (III-IV) NEF (Nucleotide exchange factor) 
binds to Hsp70, catalyzing the dissociation of ADP. (V) ATP binds to the Hsp70’s ATPase domain, enabling substrate 
release. Extrapolated from Biomolecules. 2014 Jul 17;4(3):704-24. 
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If misfolded protein damage is beyond repair, the chaperone network directs them to a degradative pathway. 
Alternatively, misfolded proteins can be sequestered in detergent-insoluble structures, termed aggregosomes. 
The two main degradative pathways for misfolded proteins are ubiquitin-proteosome system and chaperone 
mediated autophagy (CMA). The proteins within an aggresome are normally ubiquitinated and enclosed by 
intermediate filaments (IF) proteins. Aggregosomes can be finally cleared by a selective form of 
macroautophagy, termed aggrephagy 63. 
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5.2 The Ubiquitin/Proteasome system (UPS) 
UPS is the major extra-lysosomal degradative machinery responsible of targeting nuclear, cytoplasmic and 
ER short-living proteins. Proteins are marked for UPS through the binding of long ubiquitine tails, which 
guide the tagged proteins to the 26S proteasome, a highly conserved multi-catalytic ATP-dependent protease 
complex. The main components of UPS are depicted in Fig 12. 
 
 
Figure 12: Components of the ubiquitin/proteasome system (UPS). A) Substrate ubiquitination occurs through a series of 
sequential reactions catalyzed by ubiquitin-activating (E1), conjugated (E2), and ligating (E3) enzymes. The transfer of 
ubiquitin by the two main families of E3 enzymes (RING/RING-like and HECT) is depicted. E3 RING enzymes catalyze 
the transfer of ubiquitin directly from E2 to the substrate, whereas HECT E3 enzymes (E3 HECT) accept activated ubiquitin 
in the form of a thioester from an E2 before transfering it to the substrate B) Proteasome intrinsic receptors and external 
shuttle factors allow the transfer of Ub-proteins to the 26S proteasome C) Structure and subunit composition of the 26S 
proteasome. See text for details. From Cold Spring Harb Perspect Biol. 2010 Dec;2(12):a006734. 
The post-translational attachment of ubiquitins (Ub), repetitions of a single 76 aa polypeptide, directs 
eukaryotic proteins to a variety of fates and functions. Ubiquitination is best known for its role in the 
degradation of proteins, but it’s also involved in internalization or lysosomal guidance, modulation of protein 
interactions, regulation of transcription, DNA repair, and propagation of transmembrane signaling 64.  
Ub is covalently bound through a glycine carboxy-terminal to a lysine ε-amino group of a substrate. Proteins 
can be tagged by mono or poly-ubiquitination. Since Ub contains seven lysine residues, different chain 
topologies of polyubiquitination are described. The main signals that target substrates to proteasome 
clearance are tagged by K48 and K11 ubiquitination. Protein can be also ubiquitinated in multiple residues 
leading to multi-mono and multi-polyubiquitination 65. 
Substrate ubiquitination occurs through the sequential action of 3 enzymes. The C-terminal carboxyl group 
of Ub is activated through an ATP-dependent process, which results in a thioester linkage with a cysteine of 
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E1 (ubiquitin activating enzyme). Activated Ub is then transferred to the active site of E2 (ubiquitin 
conjugatin enzyme). In the final step, E3 (ubiquitin ligase enzyme) catalyzes the transfer of a single molecule 
of ubiquitin to the substrate. (Fig. 12A) 66. 
E3 is the most important enzyme in determining the specificity of substrate ubiquitination. More than 600 
E3 enzymes are estimated to be encoded in the mammalian genome 64. E3 enzymes can be classified 
according to the presence of a series of domains such as the “really interesting new gene” (RING or RING-
like) or the Homologous to the E6-AP Carboxyl Terminus (HECT). The vast majority of E3s belong to the 
RING finger ubiquitin ligase, which comprises plant homeodomain (PHD), leukemia associated fingers 
proteins (LAP) and members of the U-box family. E3 enzymes with RING domain mediate a direct transfer 
of Ub from E2 to the substrate. Oppositely, in the case of HECT E3s, Ub is first transferred to a conserved 
Cys residue of the HECT domain and then attached to the substrate (Fig. 12B). 
E3 enzyme-mediated cargo recognition occurs through two possible strategies: E3 enzyme can recognize a 
“degron” or degradative signal. However, in other cases, the specific recognition can be modulated by the 
chaperone system HSP70/HSP90, like for the member of the U-box family, CHIP.  
Once tagged, ubiquitinated-substrate proteins are directed to the proteasome for degradation. Ub-proteins 
bind directly to the ubiquitin receptors of the 19S particle of the proteosome or alternatively, interact with 
shuttle factors. These factors can be stable subunits of the proteosome (i.e. RPN10 and RPN13) or transiently 
associated shuttle proteins (i.e. p62, RAD23, Dsk2, Ddi1). After the binding to a receptor, deubiquitinating 
enzymes (DUBs) like RPN11, disassemble the polyubiquitin chains before the substrate can have access to 
the proteasome proteolytic core (Fig 12B). The 26S proteasome is a large ATP-depending multimeric 
protease complex that consists of two subunits: the catalytic 20S core particle (CP) and the 19S regulatory 
particle (RP) (Fig 12C). The CP subunit resembles a barrel and it is organized in two outer α-rings and two 
inner β-rings. The α-rings serve as a gate for the substrate entry, while the β-rings form the proteolytic 
chamber. The entrance of the substrate into the inner surface of the CP subunit is regulated by the RP subunit, 
which controls the opening and closing of the α-rings gate. RP particle consists of 19 subunits organized in 
lid and base structures. The base, in turn, comprises 4 non-ATPase subunits and six AAA’ ATPase subunits, 
which provide the energy for the substrate deubiquitination and unfolding, as well as the opening of the α-
rings gate. 
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5.3 Autophagy: between homeostasis and stress. Overview of 
Autophagy 
The term autophagy derives from the Greek auto "self" and phagein "to eat". It refers to any cellular 
degradative pathway which eventually leads to the delivery of cytoplasmic components to the lysosome 67. 
On the basis of the delivery mechanism involved, autophagy can be classified into: Microautophagy, 
Chaperone-mediated autophagy (CMA) and Macroautophagy. The three forms of autophagy are summarized 
in Fig. 13. 
 
Microautophagy implies a direct lysosomal uptake of cytoplasm by invagination. This process is ATP-
dependent and is induced by lipids and lipid-interacting proteins. During microautophagy, the formation of 
a tubular shape invagination (termed autophagic tube), controlled by the GTPase Vps1p, has been reported. 
Vesicles, which are the equivalent to autophagosomes in macroautophagy, develop at the top of the tubes. 
Afterwards, they expand within the autophagic tube and finally fuse with the lysosomal membrane 68. 
 
 
 
 
 
 
Figure 13:  Overview of mammalian autophagy. Depiction of the three types of lysosomal degradative-autophagy: 
macroautophagy, microautophagy and chaperone-mediated autophagy (CMA). In macroautophagy, proteins, organelles 
and cytosolic materials are sequestered in double membrane vesicles (autophagosome) that finally fuse with the lysosome. 
In microautophagy, small portions of the cytoplasm are engulfed by lysosomal invagination. In CMA, the pentapeptide 
KFERQ-like present in certain proteins is recognized by the HSC70 chaperone. Recognition of this sequence directs 
proteins to lysosome for degradation. Adapted from Nat Rev Mol Cell Biol. 2015 Aug;16(8):461-72. 
 
 
 
 
CMA is a catabolic pathway that targets a specific subset of cytosolic proteins to the lysosome for 
degradation. Proteins amenable to CMA need to possess a KFERQ or a KFERQ-like motif, which mediate 
the recognition by the chaperone heat shock cognate 70 (HSC70).  
HSC70 along with its co-chaperons (HSP40, BAG1, HIP and HOP) brings the substrate protein to the 
lysosomal surface. The complex interacts with LAMP-2A, which acts as a receptor, transferring the 
chaperones and the target protein into the lysosomal lumen 69. 
 
Macroautophagy (hereafter referred as autophagy) is a highly conserved process from yeast to humans. 
Regulated by the serial action of the autophagy proteins (ATGs), it consists in a course of events beginning 
with the selective or bulk sequestration of cytoplasmic components into double-membrane vesicles termed 
autophagosomes and followed by the fusion with lysosomes for the degradation of their cargo. While 
49 
 
ubiquitin-proteasome system (UPS) is specialized in the clearance of short-living proteins, basal autophagy 
is in charge of getting rid of dysfunctional/long-lived proteins and altered/damaged organelles. Likewise, a 
series of ATGs knock-out models evidenced the relevance of autophagy in the accumulation of cytotoxic 
depositions of aggregate-prone proteins. For this reason autophagy is being proposed as a basal quality 
control mechanism. In addition, autophagy acts in coordination with the UPS system for the clearance of 
ubiquitinated proteins 65, 70.  
 
 
Differently from basal autophagy, induced autophagy is activated in response to a variety of stressors (e.g. 
Staurosporine, H2O2, ER-stress, chemo, radiotherapy and metabolic stress). Functionally, it seems in charge 
of dampening the stress-mediated cytotoxic effects. Alternatively, starvation-induced autophagy would be in 
charge of maintaining cell viability by providing the building blocks when external energetic sources are not 
available 71.  
 
To date, autophagy has been involved in the regulation of many physiological processes, such as normal 
development, senescence, acclimatization, lifespan extension, immunity and defense against pathogens. On 
the other hand, its defects have been linked to myopathies, neurodegeneration diseases (such as Huntington’s 
and Parkinson’s disease), heart, liver, bowel pathologies and Cancer 72. 
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5.3.1 Autophagy in cancer 
In 2000, Hanahan and Weinberg described a list of hallmark capabilities acquired by cancer cells to evolve 
from a normal cell to a neoplastic one. Cancer development depends on the progressive acquisition of defects 
in regulatory circuits controlling cell proliferation and cell death but also on the alterations in the homeostatic 
mechanisms 11. 
The role of autophagy in tumorigenesis has been described with the metaphor of a double-edged sword 
because of its putative different effects according to the tumor stage. Broadly speaking, initiation and 
progression stages are buffered by autophagy while during progression, metastasis and therapy-resistance, 
autophagy seems to support cancer cell growth and survival. This image is being permanently questioned, 
being still impossible to answer whether autophagy favors or blocks cancer. 
One of the first links between autophagy and tumor development was the observation that the master 
regulator protein Beclin1 (BECN1) was monoallelically deleted in many breast, ovarian and prostate cancers, 
thus suggesting autophagy was a tumor suppressor mechanism 73. While becn1 -/-  mice die early in 
embryogenesis, becn1+/- mice show increased incidence of lymphomas, liver and lung carcinomas.74 
Subsequent studies documented mutations of ATG2B, ATG9B, ATG5, ATG12, UVRAG in gastric and 
colorectal cancers. In the same line, p62/Sequestosome-1, a multi-domain protein adapter participating in 
autophagy, is overexpressed in a large number of tumors. p62 is reported to promote tumor formation because 
it alters the NF-κB pathway. In an autophagy-deficient context, a raise in p62 fuels a positive loop involving 
ROS and DNA damage, which can also contribute to carcinogenesis 75.  
On the other hand, mice with a systemic mosaic of ATG5 deletion or with a liver-specific knock-out of ATG7 
induce only the appearance of liver benign adenomas, implying that the ablation of these two genes is only 
able to induce the very earliest stages of tumor development in some specific organs 76. Furthermore, recent 
studies suggest that the loss of BECN1 in human cancers is associated to the deletion of the neighboring 
BRCA1 gene, a well-known tumorsuppressor, thus weakening the evidences of Beclin-1 as a tumor 
suppressor.77  
Autophagy has been recently considered also a mechanism by means of which, cancer cells escape from 
immunosurveillance. The suppression of autophagy is reported to dampen the release of ATP, one of the 
finding-me signals for macrophage and dendrocytes (DC) precursors 6. 
The role of autophagy in an established tumor is less controversial. The structure of a proliferative solid 
tumor comprises a proliferative periphery where oxygen and nutrients are largely accessible (but transiently 
unavailable due to the chaotic and heterogeneous tumor vascularization) and a central core, characterized by 
a recurring nutrient depletion and hypoxia. The core of the tumor is also characterized by the presence of 
quiescent cells. In such conditions, cancer cells employ autophagy as a mechanism to counteract the 
metabolic stress and sustain viability 78. 
  
51 
 
5.3.2 The core pathway of canonical mammalian autophagy 
Autophagy relies on a sequence of ATP-dependent dynamic membrane modifications mediated by the 
autophagy related proteins (ATGs).  
 
Genetic screening in yeast has identified more than 30 ATGs, but only 15 are actually part of the central core 
of autophagy. A schematic overview of the canonical mammalian autophagy is depicted in Fig 14. 
Autophagy has been classically broken down in different steps: initiation (or induction), nucleation, 
elongation/completion and maturation/degradation. 
 
In mammalians, autophagy begins with the formation of the isolation membrane (also called phagofore). The 
source of the autophagosome is a debatable question. Several theories have been proposed, but two are 
predominant:  
• The autophagosome is crafted de novo by the ATG9-dependent addition of lipids from mitochondria, 
plasma membrane and Endoplasmic Reticulum 79. 
• A subdomain of ER is used for the formation of the phagophore that then expands exploiting closely 
interconnected ER domains 80. 
 
 
 
Figure 14: Overview of the mammalian autophagy core machinery. Autophagy is initiated by the formation of the 
phagophore or isolation membrane, an event regulated by the ULK-complex (1).  Next step is the nucleation, which requires 
the assembly of a multimeric complex characterized by the presence of Beclin1/VPS34(PI3K3C) (2). Vesicle elongation is 
mediated by two ubiquitin-like conjugation systems, producing ATG5:ATG12 and lipidated LC3 (LC3-II), respectively 
(3). Phagophore expansion (retrieval) is mediated by WIPI 1/2 and ATG9 (4). When the mature autophagosome is 
completely formed (completion) (5), it fuses with the lysosomal compartments (docking and fusion) (6), ultimately leading 
to the formation of the auto(phago)lysosome. Finally, the internal membrane coming from the autophagosome together 
with the cargo will be degraded by lysosomal proteases (7). See text for details. Adapted from Nat Rev Mol Cell 
Biol. 2014 Jan;15(1):65-74.  
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Induction 
The induction phase depends primarily on the ULK complex, a pretty stable complex regardless of nutrients 
abundance. The core of the ULK complex are, two serine/threonine kinases known as unc-51-line kinase 1 
(ULK1) and ULK2 (two homologs of yeast ATG1). In addition, the complex contains ATG13, FIP200 and 
ATG101. The ULK complex functions integrating upstream signals coming mainly from the mTORC1 
pathway. When mTORC1 is switched off by TSC1/2 heterodimers, ULK1 autophosphorylates itself and at 
specific residues on ATG13 and FIP200 and localizes to the phagophore. Atg101 binds and stabilizes Atg13, 
and is required for autophagy, at least in mammal.  
 
While a few interactions between ULK and the downstream ATG proteins (e.g. ATG5-complex) have been 
identified, it’s unresolved how the ULK complex and the beclin-1/PI3K3C module are interconnected. 
 
 
Vesicle Nucleation 
 
The nucleation and assembly of the rising phagofore is dependent on the Beclin1/hVPS34, a complex 
containing Beclin1 (ATG6 in yeast), hVPS34 (also called class III phosphatidylinositol 3-kinase (PI3K3C)), 
a regulatory protein kinase called p150 (also termed hVps15), Barkor (homolog of Atg14 in yeast). In 
addition, the Beclin-1/hVPS34 complex bound to UVRAG and Rubicon is also involved in the maturation 
and endosomal trafficking, (See below). 
 
Phosphatidylinositol 3-phosphate (PtdIns3P) is the enzymatic product of hVPS34 and it’s essential for the 
nucleation stage. The activity of PI3K3C is controlled by positive and negative regulators.  A positive 
regulator is VMP1 (also called TMEM49), a transmembrane protein participating in the translocation of 
Beclin-1, AMBRA1, MYD88 and Bif1 to the nascent autophagosome. On the opposite, the ER fraction of 
anti-apoptotic BCL-2 family members is known to play a negative role over nucleation. 
 
The nucleation step is physically mediated by the ATG18 analog in mammals WIPI-1/2, which belongs to 
the WIPI family of phospholipid binding effectors and interacts with PtdIns3P. WIPI2 functions controlling 
the transport of ATG9 from the phagophore to the endosome/Golgi localization. ATG9, which is the only 
identified transmembrane ATG, co-localizes with LC3 and Rab7 under starvation and it’s involved in 
carrying lipids to the nascent autophagosome.  
 
 
Elongation. 
 
During the elongation phase, the Beclin-1 complex recruits ATG12-ATG5:ATG16L multimeric complex 
and LC3-I (analog of ATG8 in yeast) to the nascent autophagosome. Soon after their synthesis, ATG12 and 
ATG5 are covalently conjugated through an ubiquitin-like system. In the first place, ATG12 is activated by 
ATG7 (E1-like) and then conjugated by ATG10 (E2-like) to ATG5. ATG12-ATG5 interact with ATG16L 
and participate in the lipidation of LC3-I. LC3-I, which routinely resides in the cytoplasm, is cleaved by 
ATG4B and then, bound to the polar head of phosphatidylethanolamine (PE) in a reaction that requires ATG7 
(E1-like), ATG3 (E2-like) and finally, the complex ATG12-ATG5:ATG16L (E3-like). The lipidated form 
(termed LC3-II) is important for expanding and lengthening the autophagosome but also for cargo 
recognition. The interactome of LC3-II includes p62/Sequestosome 1 (SQSTM1) through a region termed 
LC3-interacting region (LIR). P62 has been proposed to function as well as a cargo, regulating the packing 
and delivery of poliubiquitinated proteins and dysfunctional organelles 81. LC3-II is associated with both the 
inner and outer nascent autophagosome membrane. When the double-membrane is formed, the ATG12-
ATG5:ATG16L complex leaves the autophagosome, while only the LC3-II associated with the 
autophagosomal cytosolic surface is cleaved by ATG4B and recycled.  
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Maturation and degradation 
 
The maturation/degradation phase is dependent on the interaction between autophagosome and lysosome, 
leading to the formation of a hybrid organelle, termed autophagolysosome. The autophagosome are 
transported in a dynein-dependent manner along microtubules to the endosome or directly to the lysosome. 
The process of fusion is mediated by a series of soluble NSF attachment protein receptors (SNAREs), in 
particular Vti1b. Lysosomal hydrolases become active in response to the progressive acidification of the 
organelle. Finally, a concomitant degradation of the inner autophagosome membrane and the sequestered 
cytoplasmic content is observed. These phenomena will provide cells with a series of biomolecules that will 
be delivered from the autophagolysosome through several permeases.  
Rubicon and UVRAG are two Beclin-1 interacting proteins that play a role in maturation. While Beclin-
1:hVPS34:UVRAG up-regulate the process, the binding of Rubicon to this complex plays a negative role 82. 
In this sense, Rubicon overexpression or depletion is reported to cause a p62 accumulation or degradation, 
respectively 83. In addition, overexpression of Rubicon seems to alter the acidification of LC3-II-associated 
vesicles.  
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5.3.3 Alternative/non-canonical Autophagy 
Contrary to the canonical autophagy, the non-canonical autophagy does not require the same ordered 
activation of ATGs to trigger the degradation of cytosolic material into the lysosomes 84. To date, different 
forms of non-canonical autophagy have been reported under specific conditions, for instance in response to 
pharmacological compounds or in the context of peculiar knock-out models. 
At least three main alternative autophagic pathway can be distinguished: Beclin-1/hVPS34-independent 
autophagy, ATG5/ATG7-independent autophagy and ULK-independent autophagy. 
Beclin-1/ hVPS34 independent autophagy. A non-canonical autophagy has been reported in the absence of 
the nucleation Beclin-1/hVPS34 activity in several cancer cell lines facing different apoptotic-induced 
stressors or autophagy-inducers. This form of alternative autophagosome formation still requires the 
ubiquitin like protein conjugation system and it’s insensitive to 3-MA (the most used PI3K3C inhibitor). 
Staurosporine (STP), MK801 and etoposide have been found to induce Beclin-1 independent autophagy in 
cortical neurons 85. The same phenomenon has been shown in HeLa cells treated with Z18, a compound that 
targets the BH3 binding groove of BCL-XL/BCL-2, and in RAW 264.7 macrophage cells treated with H2O2. 
Likewise, Beclin-1 independent autophagy were identified in response to resveratrol in MCF-7 and to 
neurotoxin MPP+ in dopaminergic neuronal cells 86. 
Interestingly, human cancer cell lines exposed to Gossypol or Arsenic Trioxide undergo an hVPS34-
dependent and Beclin-1 independent form of autophagy. This finding was confirmed by some in vivo models 
of mature sensory neurons, lymphocytes, heart and liver, where the autophagosome formation can occur in 
the absence of hVPS34 and its PI3K3C activity. 
ATG5/ATG7-independent autophagy. This form of autophagy has been observed in MEFs Atg 5 -/- and       
Atg7 -/- upon prolonged etoposide exposure. Under this treatment, ultrastructural analysis by transition 
electron microscopy revealed the presence of all the stages of autophagosome biogenesis: isolation 
membrane, autophagosome, amphisomes (pre-autolysosomal vacuoles) and autophagolysosome. Based on 
the unusual lamination of the membrane forming the phagofore, it would seem that the trans-Golgi 
compartment and endosomes are the preferential source for this type of autophagy 87. 
This form of non-canonical autophagy is dependent on ULK-1/2 complex and on the nucleation activity of 
Beclin1/hVPS34 complex, but independent of the ubiquitin like protein conjugation systems (LC3, ATG5 
and ATG7) and ATG9. The GTPase Rab9 is necessary for the autophagosome elongation. ATG5-
independent autophagy seems specifically involved in mitophagy during erythrocyte maturation, suggesting 
that both canonical and non-canonical pathways may contribute to this form of organelle-specific degradation 
88
. 
ULK-independent autophagy: A form of autophagy that bypasses the canonical ULK induction has been 
reported upon glucose starvation and ammonia treatment. Although Ulk1/2 -/- double knock out cells are 
selectively impaired in the autophagy response to amino acid deprivation, autophagy is normally engaged 
during glucose starvation. Following glucose withdrawal, non-transformed cells employ alternative source 
of energy. In this context, amino acids are the preferred catabolic substrate, at least until AMPK-dependent 
β-oxidation is activated. Ammonia is the main byproduct of an increase catabolism of nitrogenous molecules. 
Both WT and Ulk1/2 DKO, subjected to low dose of ammonia (2-5 mM) activates autophagy in a ULK1/2 
and mTOR independent fashion 89. In another study, an independent group has identified FIP200-binding 
domain (FBD) in ATG16L. FBD represents a link between the ULK and the ATG5 complexes. Interestingly 
FBD is necessary for the ULK-dependent autophagy upon amino acids deprivation but dispensable for 
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autophagy activation during glucose deprivation 90. These reports also arise the possibility that 
autophagosome formation can occur in the absence of the AMPK-mTOR-ULK route of initiation.  
 
 
5.3.4 Regulation of autophagy 
5.3.4.1 mTOR: the gatekeeper of metabolism and autophagy signaling 
Autophagy is part of the metabolic intertwining circuits responsible of maintaining a balance between 
anabolism and catabolism. According to this fact, autophagy is sophisticatedly controlled by metabolic and 
energetic sensors such mTOR and AMPK. 
 
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that belongs to the 
phosphoinositide 3-kinase (PI3K) family. mTOR was first described as the target of rapamycin, a macrolide 
produced by Streptomyces hygroscopicus that gained attention for its anti-proliferative properties.  
 
mTOR is part of two complexes:  mTOR complex 1 (formed by mTOR, RAPTOR, mLST8, PRAs40) and 
complex 2 (formed by mTOR, RICTOR, mlst8 and sin1). They are clearly differenced by their components 
and functions. mTOR complexes display different sensitivities to the inhibitory actions of rapamycin. 
Furthermore, they are regulated by differential inputs and initiate distinct downstream signaling pathways. 
The mechanism of action of rapamycin it’s not fully understood. However, it has become clear that rapamycin 
forms a gain-of-function complex with FK506-binding protein (FKBP12) protein, blocking mTORC1 (but 
not mTORC2 complex) through a direct interaction with this complex. 
 
While mTORC2 is involved in the regulation of several kinases (e.g AKT and PKC) and can still indirectly 
regulate autophagy, mTORC1 acts as a rheostat, sensing the energetic status of the cell, modulating the 
proliferation and cell growth. It represents the converging hub of several pathways, integrating important 
intracellular and extracellular information from growth factors, stress, energy status, oxygen, and amino acids 
level. In this sense, it is responsible of controlling anabolic (including protein and lipid synthesis) and 
catabolic (including autophagy) processes 91. 
 
Most of the upstream regulators of mTORC1 converge on the heterodimers of tuberous sclerosis 1 (TSC1) 
and TSC2 proteins, which negatively regulate mTORC1. TSC1 and TSC2 function like a GTPase activating 
protein (GAP) on the Ras homolog enriched in brain (RHEB) GTPase. The GTP-bound RHEB, which 
normally interacts and stimulates mTORC1 kinase activity, is converted into its inactive GDP-bound state 
by the TSC1/TSC2 complex. The upstream signals transduced by TSC1/2 include growth factors (insulin, 
IGF1, etc.) and several stresses among which, hypoxia, nutrients withdrawal, and DNA damage. 
 
Under low energy and hypoxia, mTORC1 is repressed by adenosine monophosphate-activated protein kinase 
(AMPK) and REDD1, respectively. AMPK represents an important sensor of stress and the overall energy 
decrease. This protein senses changes in the AMP/ATP ratio. This situation is commonly found in response 
to glucose deprivation. In addition, AMPK can induce autophagy by direct phosphorylation of ULK1, as well 
as by the inhibition of mTORC1 through phosphorylation of TSC2 and RAPTOR. On the other hand, REDD1 
is transcriptionally induced by HIFα during hypoxia, activating TSC2 in a still poorly understood manner. 
 
mTOR regulates autophagy with a direct phosphorylation of ATG13 and ULK1/2. Interestingly after a 
prolonged period of starvation, mTOR is reactivated due to the release of nutrients from the 
autophagolysosome, a feedback that avoids excessive and prolonged autophagy. Both S6K1 (one of the most 
important downstream targets of mTOR along with E4-BP1) and the death associated protein 1 (DAP1) 
participate in this regulation, but the exact target of DAP1 still needs to be addressed 92. The regulatory 
mechanism of mTORC1 on autophagy are depicted in Fig. 15. 
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Figure 15: Regulation of autophagy by mTORC1. mTORC1 directly inhibits autophagy by the phosphorylation of specific 
nucleation complex proteins, such as ULK1 and ATG13. Dap1 is part of the negative feedback that reactivates autophagy 
after prolonged starvation. See text for details. Adapted from Cell. 2012 Apr 13;149(2):274-93.  
 
In addition, mTORC1 is strictly tuned by the level of amino acids, particularly leucine and arginine. Amino 
acids act independently from TSC1/2 and require the RAGs GTPase and the assembly of the so called 
Ragulator on the lysosomal surface, where mTORC1 translocates in order to interact with RHEB. 
 
5.3.4.2 P53: the Janus of autophagy regulation 
The p53 regulatory network on autophagy is multifaced: physiological levels of p53 dampen basal autophagy 
while stress-induced activation of p53 upregulates autophagy.  
In the absence of stress, cytoplasmic p53 displays anti-autophagic properties. This effect is exploited by p53 
deficient cancer cells to maintain ATP levels in starvation. Accordingly, human p53 -/- colon cancer cells are 
characterized by presenting greater levels of autophagy that can be reduced by re-introduction of wild-type 
(WT) p53. The mechanism behind this effect is not clear, but it seems independent of p53 transactivatory 
activity 93. 
Upon DNA damage, stabilized p53 translocates to the nucleus where induces the transcription of pro-
apoptotic genes but also of positive regulators of autophagy: AMPK β1/β2, damage-regulated autophagy 
modulator (DRAM), PTEN, TSC2, sestrins1/2. 
5.3.4.3 Regulation of autophagy by Bcl-2 family proteins 
Anti-apoptotic BCL-2 family members function as negative regulators of autophagy. For instance, this is the 
case of Beclin-1, which possesses a BH3 domain with lower affinity for the anti-apoptotic BCL-2 members 
than the other BH3-only proteins. Through these interactions autophagy and apoptosis are regulated. At the 
ER level, the interaction of Beclin-1 with BCL-2, BCL-XL or MCL-1 is preventing the assembly of Beclin-
1/VPS34 complex, a step necessary for canonical autophagy. In cells subjected to starvation, the BCL-
2/Beclin-1 complex is stabilized by the nutrient-deprivation autophagy factor-1 (NAF-1). Knockdown of 
NAF-1 diminishes the binding of BCL-2 to Beclin-1 and elicits autophagy 94. Alternatively, Beclin-1:BCL-
2 interaction can be disrupted by the JNK-mediated phosphorylation of Bcl-2 95. On the contrary, some BH3-
only proteins (BNIP3L, BAD, NOXA, PUMA and BIK) compete with Beclin-1 for the binding with the 
BCL-2 family members. The release of Beclin-1 from this complex initiates autophagy 96. 
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6 Crosstalk between autophagy and other cell death 
modalities 
6.1 Interlinks between autophagy and apoptosis 
The crosstalk between autophagy and apoptosis has recently become an extensive subject of research. The 
way autophagy and apoptosis are interconnected is context and cell line-dependent. Autophagy can be 
engaged in parallel with apoptosis as an attempt to dampen cell death. Alternatively, autophagy can be a 
legitimate means of self-killing (autophagic cell death) or engage an alternative modality of cell death, for 
instance, apoptosis.  
Three are the main possible scenarios: 
1. Autophagy and apoptosis occur as two independent processes.  
2. Autophagy regulates/primes apoptosis. 
3. Apoptosis regulates autophagy.  
 
6.1.1 Autophagy and apoptosis occur as two independent processes 
In this setting autophagy is engaged independently of apoptosis and can antagonize the deleterious effects of 
apoptosis or, oppositely, synergize with apoptosis in inducing lethality.  
Many apoptotic triggers and stresses are reported to activate both autophagy and apoptosis. In some cases, 
autophagy is activated as a pro-survival program that attenuates the toxic effects of the pro-death pathways. 
For example, autophagy is reported to maintain ER function during ER stress, through the clearance of 
aggregates and misfolded proteins, to preserve genomic integrity during metabolic stress or DNA damage 
and to buffer energy depletion facing serum or glucose starvation 97. 
In other settings, autophagy and apoptosis cooperate to ensure the dismantling of the cell. In this regard, if 
one of the two machineries is blocked, the other may gain control of the process. This could also explain why 
several validated forms of autophagic cell death were reported in cells where the apoptotic machinery has 
been disabled. However, there are multiple models where the contribution of each process in the final fate of 
the cell is well defined. For instance in T-lymphocytic leukemia cells, autophagy and apoptosis activated in 
response to arsenic trioxide are both contributing to the final death outcome. Similar evidences are reported 
in kaposi’s sarcoma treated with imatinib, PC3 prostate cancer cells treated with MG132 (a proteasome 
inhibitor) and HL-60 cells subjected to vitamin K2 97. In vivo, autophagy is involved in the post-lactation 
regression of mammary gland in mice, a process perturbed by ablation of Atg7, but relying on the apoptotic 
machinery 98.  
A similar scenario is illustrated by DRAM (damaged-regulated autophagy modulator), a stress-inducible p53-
dependent gene. In response to stress, p53-induced DRAM triggers autophagy and is essential for p53-driven 
cell death. The mechanism to elicit autophagy is unknown, only its lysosomal trans-membrane localization 
suggests a pro-autophagic function. Curiously, in the absence of p53, DRAM is merely promoting autophagy 
without affecting cell viability.  
Under certain circumstances autophagy enables several apoptotic features. In this instance, autophagy assists 
the apoptotic program without actively participating in cell dismantling. For example, autophagy-dependent 
maintenance of ATP levels may not alter the cell death fate but be necessary for the appearance of certain 
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apoptotic features, such as phosphatidylserine exposure, membrane bebbling, and apoptotic body 
formation/engulfment. 97 
When apoptosis is disabled, autophagy may gain control. A good example is represented by the cell lines 
generated from the bone marrow of Bax -/-/Bak -/- (DKO) mice, which fail to undergo apoptosis when 
subjected to IL-3 withdrawal (the default response of the WT counterpart). In this condition, DKO cells enter 
instead in a long autophagic process that causes a prominent reduction of size. The inhibition of autophagy 
in this experimental paradigm rescues such phenotype 99. 
 
6.1.2 Autophagy primes/regulates apoptosis 
In some cases, autophagy can prime caspase-dependent cell death and, as a result, the blockage of autophagy 
prevents or delays apoptosis. This is the case of light-damaged mouse retinas or photoreceptor cells subjected 
to H2O2, where autophagy shows to be necessary for apoptosis induction 100. Similarly, cerebellar granule 
cells subjected to low K+ are protected from caspase activation and cell death by the pharmacological 
inhibition of autophagy 101.  
Autophagy-dependent apoptosis does not always require the completion of the autophagic program since in 
multiple paradigms the inhibition of the autophagosome formation triggers cell survival. In this sense, the 
autophagosomes could act as a site of assembly. For instance, the autophagosome is a reported docking site 
for the assembly of caspase-8-dependent DISC. In this setting, caspase-8 interacts with FADD and ATG5, 
but also to colocalize with LC3 and p62. Another similar example comes from fibroblastic cell lines 
undergoing cell death by SKI-I, a pan-sphingosine kinase inhibitor, or bortezomib, a proteasome inhibitor. 
In these settings, the inhibition of the early stages of autophagy (in Atg3 -/- and Atg5 -/- MEFs) reduces the 
activation of caspase-8 and -3, whereas the inhibition of the last steps of autophagy (by means of bafilomycin 
A1) triggers greater levels of apoptotic cell death 102. In other instances, the ongoing autophagy can 
exacerbate the apoptotic cell death through the consumption of caspase inhibitors (IAPs) or of pro-survival 
factors. Apoptotic cell death of fly oocytes is a direct consequence of the autophagy-dependent degradation 
of IAPs, dBruce 103. 
On the other hand, ATG proteins could also trigger a lethal apoptotic signal despite of their autophagic 
functions. Interesting regulatory interlinks are reported for ATG12 and the ATG12-ATG3 conjugated 
complex. ATG12 has been recently implicated in the induction of intrinsic apoptosis through the binding of 
several anti-apoptotic BH1-BH4 proteins, such as MCL-1. This interaction is governed by a BH3 domain-
like sequence motif within a disordered region preceding the ubiquitin-like domain of ATG12 104. ATG12 is 
usually conjugated with ATG5 to form ATG12-ATG5, which is the E3-like element responsible of the LC3 
lipidation. In 2010, a new function of ATG3 as a conjugation target of ATG12 was reported. The final 
conjugation product ATG12:ATG3 had no visible effects on autophagy since its disruption did not cause any 
change in the levels of starvation- or rapamycin-driven autophagy. Nonetheless disruption of ATG12-ATG3 
complex triggered an expansion of the mitochondrial mass and protected cells from cell death mediated by 
mitochondrial pathways, including intrinsic apoptosis 105. 
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6.1.3 Apoptosis regulates autophagy 
The first evidence of apoptosis regulating autophagy came after the discovery of the interaction of several 
anti-apoptotic BCL-2 family members with Beclin-1. As described before, the anti-apoptotic BCL-2 family 
members (e.g. BCL-2, BCL-XL, MCL-1) downregulate autophagy through the binding to Beclin-1, thus 
preventing its association with VPS34. Contrarily, the BH3-only proteins induce autophagy by disrupting 
such interaction. This is the case of BNIP3, a BH3-only with a clear function as a trigger of mitophagy 106. 
Executioner caspases and other proteases (e.g. Calpains) have been reported to cleave and inactivate ATG 
proteins with the peculiarity of providing new pro-apoptotic properties to the cleaved forms. For instance, 
the caspase-dependent cut of Beclin-1 brings to the formation of a C-terminus fragment, which translocates 
to the mitochondria where it sensitizes cells to apoptosis 107. In the same line, ATG5 cleavage by calpains 
produces a 24 kDa truncated product, which functions as a BH3-only protein and promotes apoptosis by 
antagonizing the pro-survival role of BCL-XL 108. On the contrary, caspase-3-mediated cleavage of ATG4D, 
one of the variant of ATG4, promotes rather than inhibits autophagy. 
 
6.2 Interlinks between autophagy and regulated necrosis 
The relationship between autophagy and necroptosis is context specific. Autophagy has been shown to 
promote or suppress necroptosis. In some settings, autophagy is required for RIPK1 degradation and the 
inhibition of necroptosis.  Nonetheless, for example, cells subjected to obatoclax (also known as GX15-070, 
a potent inhibitors of anti-apoptotic BCL-2 family members) require autophagy for the engagement of 
necroptosis 98. In the context of Parthanatos, DNA-damage PARP-1 hyperactivation leads to ATP depletion 
with activation of AMPK and subsequent promotion of autophagy. DNA damage-induced autophagy acts as 
a protective mechanism against necrotic cell death resulting from PARP-1 activation 109. 
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V  OBJECTIVES 
 
 
The main aim of this study was to comprehend the implication of autophagy in cell death modulation.          
Two different and divergent experimental approaches were employed: starvation media (SM) and PES.  
 
 
SM represents a way to mimic metabolic stress. The adaptation to nutrients and growth factor deprivation 
represents an acquired phenotype relevant for cancer progression and metastasis. The objectives of the first 
part address the effect of SM on cell death. The specific objectives were: 
1) To evaluate cell death and engagement of autophagy in response to severe starvation by SM of 
multiple tumor and non-tumor cell lines  
2) To elucidate the mechanism of cell death in cells subjected to SM, focusing on the involvement of 
apoptosis and necrosis. 
3) To assess the contribution of canonical autophagy on SM-driven apoptotic cell death. 
4) To assess the contribution of canonical autophagy on apoptosis triggered by SM in combination with 
pro-apoptotic compounds. 
 
 
 
PES is a compound well known to block autophagic flux and other proteohomeostatic systems. The 
objectives of this part of my study were: 
 
1) To study the effect of PES on cell viability in tumor and non-tumor cell lines. 
2) To investigate the mechanism of cell death induced by PES and thus, the involvement of the three 
main cell death subroutines (apoptosis, autophagy and necrosis). 
3) To elucidate the role of p53 in PES-driven regulated necrosis. 
4) To elucidate the involvement of ROS in PES-driven regulated cell death 
5) To study the complex p53-ROS partnership in the induction of PES regulated necrosis.   
6) To shed light on the paradoxical protective function of BAX in PES-induced regulated necrosis. 
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1 Discussion paper 1 
“Autophagy exacerbates caspase-dependent apoptotic cell death after short times of starvation” 
 
Our experiments uncovered a pivotal role of autophagy in priming caspase-dependent apoptotic cell death 
upon growth factor, glucose and nutrient deprivation (starvation media, SM), while triggering cell survival 
at long times. Our results put together both outcomes under one single trigger: starvation. 
 
 
Mechanisms of SM-induced cell death tolerance 
Within a solid tumor, cancer cells undergo transient periods of starvation that translate into a gradient of 
metabolites (glucose, non-essential aa, etc.) oxygen and growth factors from the tumor core to the external 
and more irrigated layers of the cancer mass. The ability to stimulate angiogenesis but also to tolerate 
metabolic stress is a critical factor for cancer survival and progression. The cell tolerance to different types 
of starvation is a matter of study. For instance, deprivation of a single component at a time is a standardized 
experimental approach, but can lead to compensatory metabolic readjustments, especially if certain nutrients 
are depleted. In our studies, we employ starvation media (SM), which is one of the most severe starvation 
forms (no glucose, no nutrients and no growth factors). Under this condition, we avoid any possible 
compensatory effects on metabolism. This environment induces cells death (and autophagy) in all the 
analyzed cell lines (MEFs, PC3, SH-SY5Y, MCF-7, HeLa, DU145, HEK293, U87MG, HCT116). WT 
MEFs, an immortalized non-tumor cell line, was the most sensitive to SM-driven cell death. This 
characteristic, in addition to the availability of several isogenic knock-out cell lines, made them a suitable 
model for our experiments. In this cell line, SM-induced cell death was alleviated by the addition of many 
single metabolites. Glutamine and glucose, two of the most frequent energetic sources for a cell, exerted a 
protective effect facing SM-driven lethality. For instance, WT MEFs subjected for 24h to SM plus 250 µM 
of glutamine were completely protected facing cell death. Similarly, 2 g/L of glucose markedly reduced 
caspase activation and mitigated cell death (data not shown). Interestingly, WT MEFs cells underwent 
starvation-driven cell death at times earlier than 24h. In sharp contrast, other cell lines (both tumoral and 
non-tumoral) were able to survive starvation for longer times. There are different hypothesis to explain the 
metabolic tolerance of some employed cell lines to SM-driven cell death:  
• Increased β-oxidation is responsible of SM-resistance. Cells subjected to SM undergo metabolic 
changes aimed to maintain a functional level of ATP. In this setting, ATP can be obtained from 
energy stores (glycogen, lipids droplet) and metabolic intermediates recycled through autophagy. 
Increases in the AMP/ATP ratio are sensed by AMPK. Upon its activation, AMPK reestablishes the 
energy levels by inhibiting anabolic and enhancing catabolic pathways (e.g. β-oxidation) 89. We have 
several evidences that support the activation of AMPK in our models. For instance, cells treated with 
SM plus 250 µM AICAR (an analog of adenosine monophosphate that acts as an activator of AMPK) 
display a reduced caspase activity. On the opposite, the pharmacological inhibition of β-oxidation 
(Etomoxir, TOFA, Cerulenin and C75) exacerbates SM-driven cell death in all the employed cell 
lines (data not shown). Thus pointing out to the lipid β-oxidation as a central player in the SM-driven 
cell tolerance. 
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• SM-induced cell death is dampened by hyperactive prosurvival pathways in cancer cell lines. 
In normal proliferating cells, nutrient uptake and metabolism are tightly regulated by growth factors. 
The growth factors (GF) signaling cascades converge mostly on the RAS/ERK or PI3K/AAK 
pathways. As a consequence, growth factors (GF) trigger a plethora of effects, such as cellular 
growth, cell survival and metabolic reprogramming 110. Multiple cancer subtypes undergo alterations 
of RAS and AKT cascades that act as permissive events for the tumorigenic process. In normal cells, 
long periods of glucose deprivation trigger the activation of Akt 111, while serum deprivation leads 
to the inactivation of the PI3K/AKT pathway 112. Despite we do not have information on the status 
of the AKT pathway in the studied cell lines, it is possible to surmise that the presence of an abnormal 
activation of these oncogenic pathways may contribute to prolonged cell viability by dampening 
apoptosis and promoting the cell survival. In this sense, high levels of AKT in pancreatic cancer cell 
lines seems to participate in the resistance facing a complete starvation without being a requisite 113.   
 
• Secreted paracrine factors promote survival of cultures exposed to SM.  In vitro, cells can 
condition the culture medium by releasing a series of protein, lipid, sugar or oligonucleotide-based 
factors. Secretion can occur through classical (i.e. ER/Golgi-dependent manner) and a non-canonical 
secretory pathways (i.e. shedding of plasma microvesicles, direct efflux through plasma membrane 
and exosomes) 114. As mentioned in the previous section, these products could converge on the 
activation of pro-survival pathways such as RAS/ERK and PI3K/AKT. In this sense, cancer-
associated fibroblasts undergoing autophagy release metabolic intermediates (lactate) to sustain the 
tumor growth 115. This phenomenon has been termed as the reverse Warburg effect. Thus being one 
of the best proof-of-concept to the proposed hypothesis.  
 
• Engulfment of apoptotic bodies from a subpopulation of SM-driven apoptotic cells contributes 
to the survival of a remaining starved subpopulation. Cancer cells are able to engulf dying or 
alive neighbouring cells  in a process generally termed cell engulfment 116, 117. Different forms of cell 
engulfment exists, among which cannibalism, phagocytosis, entosis. Phagocytic activity has been 
for example observed in cancer cells line such as MCF-7 118, while cannibalism has been reported in 
bladder cancer (transitional cell carcinoma), breast cancer, lung carcinomas. This acquired capacity 
represents a sign of the aggressiveness of the tumor and, in condition of deprivation, another means 
to fuel the metabolism of part of the culture. SM-Resistant cells may feed on apoptotic bodies from 
their weaker neighbouring cells or, alternatively, eat “marked” alive cells. The factors playing a role 
in this process remain an incognita.  
 
Pro-death role of autophagy at short-times of SM 
Cultures subjected to starvation media (SM) display clear signs of autophagy and activation of the caspase-
dependent intrinsic apoptotic pathway. This phenomenon has been reported in several experimental 
paradigms 119,  120, 121, 122.  
Autophagy-incompetent cells (Atg 5 -/- and 3-MA treated cells) shown less cyt C release and an attenuated 
caspase activation, and thus they are protected facing SM-driven apoptosis. Based on these observations, we 
concluded that at short times, autophagy acts as a mechanism of MOMP-dependent apoptosis. On the 
contrary, bafilomycin A1 – an inhibitor of the late stages of the autophagic pathway – was unable to confer 
cytoprotection at the same time points (data not shown). These results, suggest that the engagement of the 
autophagic machinery is crucial for the induction of MOMP and exclude the involvement of mechanisms 
initiated at the autophagolysosome stage. Furthermore, autophagy-incompetent cells (Atg 5 -/- and 3-MA 
treated cells) subjected to SM are protected facing a series of apoptotic compounds (STP, Etoposide, 
Camptothecin). Altogether, these results corroborate that the autophagic machinery - at least it the context of 
nutritional and trophic deprivation – is promoting spontaneous or pharmacologically-induced apoptotic cell 
death. The literature offers several possible explanations to this phenomenon based of a complex regulatory 
network between BCL-2 family members and autophagy. These are the hypotheses we favor the most: 
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• The autophagy-dependent sequestration of anti-apoptotic BCL-2 family triggers the intrinsic 
pathway of apoptosis. The sequestration of anti-apoptotic proteins within the autophagosomes 
could occur through selective or not selective mechanisms. A plethora of poly-ubiquitin chain 
binding proteins have been identified. For instance, p62 can selectively target a series of specific 
proteins to the autophagosomes during CMA. Nonetheless, GATA4, a transcription factor involved 
senescence and inflammation is the first protein to be specifically-targeted to the autophagosomes 
via p62 123. Finally, the unbalance between mitochondrial pro-apoptotic and anti-apoptotic proteins 
will trigger the MOMP. 
• SM-driven upregulation of Beclin-1 favors apoptosis by promoting the clearance of MCL-1. 
This hypothesis is supported by the recent observed inverse correlation between levels of MCL-1 
and Beclin-1, a phenomenon responding to their reciprocal regulation due to a competition for a 
common deubiquitinase - USP9X - 124. In our setting, we observed an increase in the level of Beclin-
1 (data not shown). Accordingly, such increase would lead to an enhanced degradation of MCL-1, 
thus prompting the intrinsic apoptosis pathway.  
• Autophagy upregulates BH3-only proteins. MOMP is positively regulated by a series of 
sensitizing and activating pro-apoptotic proteins. The proposed hypothesis would imply an 
autophagy-dependent upregulation of at least one BH3 only protein. To our knowledge, there is no 
experimental evidence of autophagy playing this role. On the other hand, as described in section 
5.3.4, the apoptotic-driven cleavage of specific autophagic proteins generates truncated fragments, 
containing a BH3 domain. For example, caspase-3, -6 and -9 dependent cleavage of Beclin-1 
generates a truncated C-terminal fragment, which prompts the release of pro-apoptotic factors from 
isolated mitochondria.  In a similar manner, the calpain-mediated cleavage of ATG5 generates an N-
terminal 24 kDa fragment that interacts with BCL-XL sensitizing cells to apoptotic cell death. In our 
setting, Calpeptin (a calpain specific inhibitors) wasn’t able to exert any significative protection at 
short times, thus indirectly excluding this possibility (data not shown).  
 
Pro-survival role of autophagy at long times of SM 
At long times of treatment, our results unveil a pro-survival function of autophagy. After 12h SM, 
Autophagy-incompetent cells (3-MA treated and Atg 5 -/-) exhibit a greater cytotoxicity (Paper 1, Fig. 5D) 
than the autophagy-proficient ones. Surprisingly, this event occurs despite a similar or greater release of cyt 
C (Paper 1, Fig 3A, 3B, 4B) and diminished caspase activation (Paper 1, Fig 3C, 3D, and 4C). This implies 
that SM-driven autophagy undergoes a shift of function determined by time. Blockage of autophagy under 
most deprivation models is a well-known trigger of cell death 125. An exception to this rule is the glucose 
starvation paradigms. Under this condition, autophagy is not activated and has no reported protective effect 
126
. In our setting, time would control the change between the pro-death/survival effects of autophagy. These 
are the hypothesis we favor the most to explain the switch of function of autophagy towards cell survival:  
• Time controls the appearance of the pro-survival function of autophagy. We propose that over 
time, the pro-apoptotic effect of autophagy is overcome by its protective function. This could be 
cause by different possible mechanism which requires a certain time to occur. Autophagy could 
promote the expression of unknown prosurvival factors, the recycling of nutrients or the specific 
induction of mitophagy. Mitophagy is for instance, described to limit the release of pro-apoptotic 
factors though the clearance of damage mitochondria, as reported in other paradigms 119. 
 
• Autophagy promotes cell survival through the suppression of necrotic cell death. Necrosis and 
apoptosis represent the two extremes of a continuum of cell death subroutines 33. Changes in specific 
biochemical parameters (e.g. ATP, antioxidant levels) or in the magnitude of a specific stress can 
lead to a conversion of apoptosis to necrotic cell death 127. In light of the discrepancy between caspase 
activation and cell death, we surmise that prolonged SM treatment will engage caspase-independent 
(necrotic) cell death. We favor the following models to explain the involvement of necrosis in our 
setting: 
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- Energy based-model: ATP is used as the most frequent energy molecule within a cell and 
accordingly, sustaining sufficient ATP levels is a capital event for cell survival. A decrease in 
the ATP content is a powerful signal to trigger cell death. The kinetics of ATP collapse are 
determinant in the commitment to either apoptotic or necrotic cell death 128. 
In our model, necrosis could occur in a subpopulation of cells already succumbing by the 
intrinsic apoptotic cell death. In this sense, progressive energy withdrawal would lead to a greater 
proportion of cells being committed to necrotic, rather than apoptotic death 129. In SM, the switch 
from apoptosis to necrosis would befall downstream of the apoptosome stage, as a consequence 
of the first phase of autophagy-dependent MOMP with loss of mitochondrial potential (∆ψm) and 
subsequent bioenergetics catastrophe. 
 
Alternatively, necrosis could occur in an apoptotic-resistant subpopulation that survives the 
initial metabolic stress. In this case, the ATP level collapse would be a consequence mainly of 
an exhaustion of substrate to catabolize. This possibility is supported by the experiments in the 
isogenic Bax and Bak (DKO) knock-out MEFs. DKO MEFs display complete protection facing 
SM for 24h and succumb in the following 48h by necrosis as proved by the absence of caspase 
activation up to 72h (data not shown). This results corroborates the induction of necrotic cell 
death in DKO MEFs at long times of SM treatment and suggest that the same phenomenon could 
be occurring before 24h of treatment in WT MEFs. In addition, the lack of caspase activity 
excludes the involvement of caspase-8-dependent apoptotic cell death in our experimental 
paradigm.  This is of special relevance when taking into account the caspase-8-mediated 
mechanisms of apoptosis described for DKO MEFs subjected to long times glucose starvation 
130
.   
In deprivation models, autophagy is in charge of maintaining functional ATP levels. In this 
scenario, impairment of autophagy would accelerate energy depletion and promote cell death as 
reported previously by other authors 46.  This hypothesis is also reinforced by the morphological 
observation in HeLa cells, a cell line characterized by a slower kinetics of death. In HeLa cells 
we observed a concomitant apoptotic and necrotic morphology at long times of SM (data not 
shown). 
- A rapid and robust caspase-activation increase leads to necrotic cell death in autophagy-
incompetent cells. Our results shows that at long times of SM, autophagy-incompetent cells 
(WT MEFs cells treated with 3-MA and Atg5  MEFs -/-) display a more rapid kinetics of caspase 
activation when compared to autophagy proficient cells (paper 1, Fig. 3D and 4C). We propose 
that such abrupt increase could promote caspase-dependent necrotic cell death in cells with 
impaired autophagy. Accordingly, autophagy would promote survival by avoiding the 
engagement of this form of cell death. A form of Caspase-dependent necrotic cell death have 
been for example reported in neuroblastoma cells subjected to Chelerythrine. Chelerythrine 
induces an early and robust caspase-activation which leads to regulated necrosis. In this model, 
necrotic cell death can be turned into apoptosis by modulating ROS level with thiolic 
antioxidants 131. Upon SM, we observed an increase of ROS production over time, but we never 
explored the protective role of thiolic antioxidants.  
 
• Lethal gain of function of a compensatory form of autophagy.  Long-term inhibition of 
macroautophagy can lead to compensatory upregulation of CMA132 or of non-canonical forms of 
autophagy 87, 86. After long times of SM we report a slight decrease of p62 in autophagy incompetent 
cells (3-MA treated WT MEFs cells and Atg5 -/- MEFs) consistent with an engagement of  alternative 
forms of autophagy (Paper 1, 4A, 5B). Accordingly, we propose that an engaged compensatory form 
of autophagy would acquire a lethal gain of function and promote greater cell death than in the 
presence of canonical autophagy. To our knowledge though, no reports exist in this direction, while 
protective function of compensatory CMA has been for example documented in Atg5 -/- MEFs 
subjected to pro-apoptotic triggers such as ROS-generating menadione and UV light 132. 
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2 Discussion paper 2 
“2-Phenylethynesulfonamide (PES) uncovers a necrotic process regulated by oxidative stress and p53”  
This paper underscores the fine interrelation of ROS and p53 in triggering regulated necrosis.  Because of its 
high immunogenic nature, necrotic cell death is increasingly acquiring attention as a possible alternative to 
the traditional pro-apoptotic chemotherapeutic compounds. The biological effect of PES makes it a good 
candidate for therapeutical administration, since in vitro, PES is reported to not harm non-neoplastic cells. In 
vivo though, PES is reported to potentially affect kidney and liver. However, the possible combination with 
BSO (Paper 2, Fig. 4D) could markedly reduce these adverse effects. PES is reported to impair capital 
homeostatic mechanisms: the molecular chaperone HSP70, the lysosomal-degradative autophagy, UPS but 
also to block the translocation of p53 to the mitochondria. In addition to what has been discussed in the 
“discussion section” of each publication, we propose the following topics: 
 
Role of autophagy in PES-induced necrosis 
Cells subjected to PES display an early increment of LC3-II, a sign of lysosome blockage when accompanied 
with steady levels of LC3-II in the presence of bafilomycin A1 or chloroquine (data not shown). Accordingly, 
ultrastructural images of PES-driven necrosis shows the abundant presence of autophagosomes containing 
cytoplasm and organelles. These two facts together are pointing out to a blockage of the maturation step 133. 
Autophagy-incompetent cells (3-MA and Spautin-1 treated cells, Paper 2, Fig. 3A) are more sensitive to PES. 
In the same line, Atg5 -/- MEFs are more prone to undergo PES-driven cell death (data not shown). To 
understand the protective role of autophagy in the cytotoxic profile of an autophagy-suppressor (PES), we 
propose a protective role of autophagosomes sequestering damaged cell components and thus, avoiding PES-
driven necrosis.  This hypothesis is consistent with the role of autophagy counteracting proteotoxicity, 
formation of aggregates and ROS. In addition to its role increasing the proteotoxicity, PES is a powerful 
inducer of ROS. In this sense, a mild increase of ROS triggers a specialized form of autophagy, termed 
mitophagy 134, which would sustain viability by buffering oxidative stress through the clearance of damaged 
mitochondria. These two cellular responses to PES would be at the origin of PES-mediated increase of 
autophagic markers (LC3-II). 
 
ROS-p53 partnership in PES-driven regulated necrosis 
In context-specific situations, both ROS and p53 can trigger either apoptosis or necrosis according to the 
magnitude of the stimulus. PES treatment induces an early ROS increase and an upregulation of p53. By 
using the fluorophore dichlorofluorescin diacetate (DCFDA), we observed that PES has direct oxidant 
properties (data not shown). The upregulation of p53 is dependent on ROS since the presence of thiolic-
antioxidants (i.e. DTT) strongly diminishes p53 levels (Paper 2, Fig 7A). However, the mechanism of p53 
upregulation remains a subject of debate. In this sense, we anticipate two possibilities: first, the upregulation 
of p53 is a consequence of ROS-dependent DNA damage and the subsequent engagement of the DNA 
damage response (DDR). Second, ROS-dependent upregulation of p53 is a consequence of post-translational 
modifications occurring via the engagement of protein kinases, such as p38α, MARK (mitogen activated 
protein kinase), ATM (ataxia-telangiectasia mutated protein) and ERK (extracellular signal-regulated 
kinases) 135.  
In our experiments, we observed that the inactivation of p53 by genetic or pharmacological strategies resulted 
in diminished ROS, thus establishing a clear link between p53 and ROS.  The predominant localization of 
p53 in a chromatin-enriched fraction and the upregulation of p21 are two characteristics of PES-treated cells 
(Paper 2, Fig. 6A and 6B). These facts point out to a transcriptional function of p53. In this sense, we propose 
the following possibilities to explain the transcriptional mechanisms of p53 promoting ROS: 
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• p53-dependent metabolic changes. Active p53 induces the transcription of “TP53-induced glycolysis 
and apoptosis regulator” (TIGAR) and cytochrome oxidase 2 (SCO2) 136. TIGAR redirects glucose 
metabolism towards the pentose phosphate pathway (PPP) by blocking phospho-fructokinase-1 
(PFK1) with a neat increase of NADPH, which in turn instigates ROS generation.  The induction of 
SCO2 – an essential element for maintaining the function of the mitochondrial respiratory chain – 
stimulates the oxidative phosphorylation.  
• The upregulation of p53 is reported to generate ROS through the transcription of genes such as, 
BAX, PUMA, NQO1 (quinone oxidoreductase, PIG3) and proline oxidase (POX, PIG6), which 
function as uncoupling mitochondrial proteins. In addition, p53 suppress the transcription of genes 
from the enzymatic antioxidant arsenal, such as manganese superoxide dismutase  (MnSOD), PIG12, 
Aldehyde Dehydrogenase 4 (ALDh4), Glutathione peroxidase (GPX) 135. 
 
 
 
PES-driven necrosis in the context of other p53-dependent necrotic cell death models 
 
p53 is implicated in the necrotic cell death from two other models. WT and Bax -/-, Bak -/- (DKO) MEFs 
subjected to H2O2  undergo CYPD-dependent regulated necrosis. In order to trigger necrosis, p53 needs to 
translocate to the mitochondria where it interacts with CYPD, regulating the opening of MPTP. Despite this 
model matches our observations (p53 driving necrosis), this possibility is excluded by two reasons: first, PES 
was initially identified as a pharmacological inhibitor of p53-translocation to mitochondrion and second, 
cyclosporine A (an inhibitor of CYPD) is unable to rescue WT MEFs from PES-driven necrosis (data not 
shown).  Yet in another analogous system, MEFs DKO succumb to etoposide by undergoing a form of 
necrotic cell death largely dependent on p53-mediated transcription of Cathepsin Q, in cooperation with 
ROS-driven DNA damage 137. HSP70, the molecular target of PES, is known to regulate the lysosomal 
integrity 138. In a previous publication, the lysosomal permeabilization and release of cathepsin D were the 
molecular triggers of PES-driven necrotic cell death. In this setting inhibition of cathepsin D proteolytic 
activity by pepstatin A rescued the viability of PES-treated cultures. The inhibition of aspartyl peptidases 
such as cathepsin D with pepstatin A or with PepA-P (pepstatin A penetratin, a much soluble analog of 
pepstatin A) was unable to rescue ontogenically different cell lines from PES-driven toxicity. In addition, the 
lack of a consistent protection conferred by Z-FG-NHO-Bz (a general inhibitor of cysteine cathepsins such 
as cathepsin B, cathepsin L and cathepsin S) was suggesting that PES-driven necrosis was independent of 
cathepsins. 
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3 Discussion paper 3 
“Cell death induced by 2-phenylethynesulfonamide uncovers a pro-survival function of BAX” 
 
In this paper we uncovered a pro-survival function of BAX in the context of PES-driven necrotic cell death.  
 
Employing isogenic knock-out MEFs, we evaluated the contribution of pro-apoptotic effector BAX and BAK 
in PES-driven necrosis. Surprisingly, BAX-incompetent MEFs (Bax -/- and DKO-) were more prone to die 
when compared to the WT counterpart (Paper 3, Fig 2A). Accordingly, PES cytotoxic effect was dampened 
by the reintroduction of functional BAX in DKO MEFs (Paper 3, Fig. 3A). Morphologically, PES-treated 
WT MEFS showed the presence of images of mitochondrial fusion. As suggested by this ultrastructural 
characteristic, we surmised that mitochondrial dynamics modulation could be the key mechanism for BAX 
pro-survival function. In this sense, BAX is reported to promote fusion by its interaction with mitofusion-2 
(MFN2). For this effect, BAX needs to shuttle from the cytosol to mitochondria and interact with MFN-2 139. 
This is confirmed by the loss of protective effect when a mutated form of BAX (BAXS184E, unable to 
translocate to the mitochondria) is employed (Paper 3, Fig. 3A). Mdivi-1 is an inhibitor of fission, which acts 
by targeting the GTPase activity of Drp1, thus promoting fusion. The Mdivi-1 protection in BAX-competent 
cells facing PES, corroborates the protective effect of fusion in PES-driven necrosis. However, this 
protection, though still active, is much reduced in the background of BAX-deficient cells. Thus indicating 
that BAX is partially mediating Mdivi-1-protective effects. 
This manuscript suggests that an impairment of the pro-apoptotic protein BAX is predisposing cells to 
undergo necrotic cell death. We find several manuscripts that are against this idea. Some authors have 
recently reported a pro-necrotic function of BAX in the context of CYPD-regulated necrosis. Bax and Bak- 
null mouse were protected from myocardial infarction. Moreover DKO MEFs subjected to ionomycin - a 
Ca2+ ionophore described to elicit MPTP opening - were protected facing necrotic cell death. Moreover, it 
was demonstrated that necrotic cell death was promoted by BAX-dependent fusion 140. The apparent 
contradiction with our results can be explained by the different mechanism of action involved in Ionomycin 
and PES-driven cell death, since PES-induce necrotic cell death doesn’t seem to involve the opening of 
MPTP, as mentioned before. 
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VIII CONCLUSIONS 
 
 
 
 
SM-driven cell death. 
1. All the studied cell lines engage canonical autophagy, mediated by ATG5 and Beclin-1, upon 
starvation media (SM) treatment.  
2. SM induced caspase-dependent intrinsic apoptotic cell death, since BAX and BAK proteins 
deficiency implied complete protection after 24h.  
3. At short time of SM treatment, autophagy incompetent cells (Atg5 -/- and 3MA treated cells) 
displayed reduced MOMP and release of cytochrome C, which is translated into inhibition of 
cell death. 
4. At long time of SM treatment, autophagy incompetent cells showed increased ratios of cell 
demise. 
5. Autophagy-incompetent cells were more resistant facing pro-apoptotic compounds (etoposide, 
staurosporine and camptothecin).  
 
 
PES-induced cell death: 
1. PES triggers a caspase-independent non-apoptotic cell death. Necrostatin-1 lack of protection 
excluded RIP1-dependent necroptosis.  
2. Autophagy is protective facing PES as proven by both pharmacological and genetical autophagy 
ablation.   
3. ROS are a crucial element in PES cell death. This is proven by the early ROS biogenesis and the 
protection conferred by thiolic antioxidant agents.  
4. p53 contributes to PES-induced cell death in a transcriptional-dependent manner. Accordingly, 
p53 was predominantly in the chromatin-enriched fraction.  
5. ROS and p53 are engaged in a positive feedback loop leading to the final cell death outcome. 
6. PES-induced cell death is more prominent in BAX protein deficient cells, thus underscoring a 
putative pro-survival function of BAX.  
7. PES-induced cell toxicity is dampened by induction of mitochondrial fusion, which is promoted 
by BAX protein. 
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